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Abstract 
 
Alterations in the Local Environment of Axons Converge on Intrinsic Pathways That 
Support Growth of Adult Neurons 
Ashley Lauren Kalinski 
Jeffery L. Twiss, M.D., Ph.D. 
 
 
 
 
Neurons are a distinct population of cells that communicate information allowing us to 
think, move and respond to our environment.  A typical neuron has a cell body, 
multiple dendrites and a single axon.  Dendrites communicate information across short 
distances, while axons carry information across long distances.  When the connection 
between the cell body and the axon’s target is interrupted, functional deficits occur 
which can be permanent if the connection is not restored.  The peripheral nervous 
system (PNS) can respond to axonal injury relatively well, with regeneration 
spontaneously occurring.  Regeneration failure in the central nervous system (CNS) is 
from a decreased intrinsic growth capacity and an inhibitory extrinsic environment. To 
understand how to increase regeneration in the CNS, I took my understanding of some 
of known neural repair mechanisms in the PNS.  The work described below focuses on 
mRNA localization, local protein synthesis, alterations in the cytoskeleton and 
mitochondrial transport.  By providing a permissive environment to encourage CNS 
axon regeneration (Chapter 2) or by targeted inhibition of HDAC6 (Chapter 3) I provide 
data that supports intrinsic and extrinsic factors converge on mechanisms in the distal 
axons.    
"
!
 
 
 2!
CHAPTER 1: Neuronal Transport and Spatial Signaling Mechanisms in 
Neural Repair1 
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Abstract 
Communication in the nervous system requires axonal processes that often traverse long 
distances to connect neurons to their targets.  Injury of axons disrupts this intercellular 
communication, and neural function can only be fully restored by regeneration of axons 
with reinnervation of their targets.  Neuronal function depends on precise trafficking of 
macromolecules and organelles along axons, which is driven by motor proteins.  
Regeneration requires a near complete shift in this trafficking to support growth of the 
injured axon.  This brings a rather daunting task considering that axons can extend for a 
meter or more in humans.  Here, we highlight recent work that has uncovered 
previously unrecognized means to support growth of axons and provides new insight 
into the mechanisms needed for regeneration. 
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Introduction 
Neurons form the circuits that control and coordinate all animal behavior.  These circuits 
are vital for normal function of the brain, spinal cord and peripheral nerves.  
Intercellular communication generated by transfer of electrical activity between neurons 
and from neurons to target tissues is needed for every movement, sensation and thought 
produced.  A typical neuron is composed of three parts: a cell body, several dendrites, 
and an axon.  The dendrites traverse short distances (≤ 2 mm) and bring activity to the 
cell body, while the axons are much longer and transmit activity away from the cell 
body.  A neuron uses membrane depolarization to rapidly convey the information that is 
encoded by neural activity, from ‘post-synaptic’ sites in dendrites to the ‘pre-synaptic’ 
sites at the ‘termini’ of axons (i.e., intracellular communication).  Arrival of such an 
‘action potential’ at the axon terminus triggers release of neurotransmitters to propagate 
information across neural circuits or directly to the neuron’s target (i.e., intercellular 
communication).  The human neural circuits that connect motor cortex to spinal cord to 
muscle cover a distance approaching two meters in some individuals.  It is the axons of 
the motor cortex neuron and the spinal motor neuron that cover these long distances in 
the spinal cord and peripheral nerves, respectively.  Disruption of axons through injury 
or disease blocks normal transmission of this neural activity and these long axonal 
processes are particularly vulnerable to damage.  
While propagation of action potentials across these distances occurs on a 
millisecond time frame, neurons also use slower forms of intracellular communication 
by conveying organelles, protein complexes, and RNA-protein complexes anterogradely 
and retrogradely in axons and dendrites.  Axonal transport has been particularly well-
studied, and has historically been separated into fast and slow components based on the 
speed of labeled proteins moving within axons.  The fast component travels around 100 
mm/day, while the slow component travels around 1 mm/day (Shah and Cleveland, 
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2002).  The cargos that move in the fast component are important for the growing tips 
of developing axons (‘growth cones’) and for the proper function of mature synapses.  
These include organelles, membranes, proteins, and RNAs.  Fast axonal transport also 
conveys signals to the cell body of the neuron that can regulate gene expression.  The 
slow component of axonal transport ferries cytoskeletal polymers and other soluble 
proteins for maintenance of axon integrity (Shah and Cleveland, 2002).  Movement of 
organelles and complexes within axons and dendrites is essential for neural function 
and plays key roles in neural repair.   
‘Molecular motors’ or ‘motor proteins’ play the role of pack animals and 
messenger pigeons to move cargoes to and from the neuron’s cell body along axons and 
dendrites. There are several types of motors but all share certain attributes, being multi-
subunit protein complexes that harness the energy of ATP hydrolysis to move along 
"cytoskeleton" tracks in axons and dendrites.  The rates at which motors ferry cargo 
depends on a number of criteria, but in vitro speeds of individual mammalian motors 
and also membrane bound vesicles in axons have been clocked at up to 4 µm/sec.  This 
speed is probably not maintained consistently, as transport cargos are frequently 
observed to pause and even reverse directions within axons and dendrites.  Nonetheless, 
the movement of cellular components over very long distances in relatively short 
amounts of time is a rather herculean task that requires a significant expenditure of 
energy.  Regulation of motor protein motility, cargo composition and the organization of 
the cytoskeleton tracks within neurons can dramatically influence neuronal function, 
particularly during the repair of neural connectivity after injury.  Motor-dependent 
transport mechanisms are also prime targets for dysregulation in disease processes that 
affect the nervous system.   
This chapter will cover the contributions of this subcellular trafficking to neural 
repair, focusing on the axon.  During development, axon growth is characterized by a 
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rapid elongation phase until targets are reached.  At this point an alternate mode of 
arborizing growth allows axons to contact target cells and initiate synaptogenesis.  This 
short distance sprouting of axons may also underlie a pre-synaptic contribution to 
synaptic plasticity.  It should be noted that development and regeneration of axonal 
processes share many common mediators; so much of this chapter will also be relevant 
to events in developmental growth.  Furthermore, many of the mechanisms outlined 
here are also relevant for repair of dendritic processes; although we focus on the repair 
of axons because of their fundamental importance in long-range communication in the 
nervous system; the reader is referred to ‘Further Reading’ section for recent publication 
examining mechanisms of dendrite repair.  
Constituents for Intracellular Communication and Trafficking in Neurons 
The Neuronal Cytoskeleton Provides Structure, Highways for 
Communication, and Growth Functions  
The three components of the neuronal cytoskeleton, microfilaments, intermediate 
filaments, and microtubules, provide structural integrity for mature axons and 
dendrites.  Their continued maintenance throughout the life of the animal supports 
normal axonal and dendritic function.  During developmental and regenerative events 
the cytoskeleton itself is highly dynamic; polymerization and depolymerization of 
microtubules and microfilaments in the distal ends of axons (and dendrites) contributes 
to both growth and pathfinding for axons and dendrites (Lowery and Van Vactor, 2009).  
Post-translational modifications to cytoskeletal proteins and proteins associated with the 
cytoskeleton can contribute to neuron's cytoskeletal dynamics – for example, cyclin 
dependent kinase 5 (Cdk5) impacts all three components to regulate neuron’s 
cytoskeletal dynamics (Smith, 2003).  Motor proteins can contribute to cytoskeletal 
dynamics by moving short segments of cytoskeletal polymers or oligomers as cargo 
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(Shah and Cleveland, 2002).  This is particularly relevant during axon growth and 
arborization, but even after synapses are formed, transport of cytoskeletal components is 
likely to be important for maintenance of axons.  The bulk of this movement appears to 
occur much more slowly than the speeds typically associated with fast axonal transport.  
However, this slow movement (and perhaps all of the slow component of axon 
transport) is thought to be driven by ‘fast’ motors that move the cargo intermittently (Li 
et al., 2012). 
Microfilaments 
Microfilaments are composed of two strands of actin monomers twisted into 
helical filaments that have intrinsic polarity.  All cells, including neurons have a 
microfilament-rich, mesh-like network on the cytoplasmic side of the plasma membrane.  
This ‘cortical actin’ has been proposed to provide a tethering platform for non-
translocating but active motors, allowing them to function in unison to move small 
microtubules and attached cellular components within axons and dendrites (Myers et 
al., 2006).  Polymerization and depolymerization of microfilaments at the distal end of 
growing axons and along the axon shaft, respectively, also play key roles in axon growth 
and branching.  A large number of proteins have been identified that regulate actin 
dynamics and the spatial organization of actin filaments in growth cones (Lowery and 
Van Vactor, 2009). 
Spectrin is another filamentous protein that is concentrated beneath the plasma 
membrane, providing a crosslink for the actin cytoskeleton and anchor for complexes of 
signaling and structural proteins, including membrane linked proteins complexes 
(Machnicka et al., 2014).  Different spectrin isoforms are concentrated in subdomains of 
the axon (e.g., axon initial segment, nodes of Ranvier) that are needed for neural function 
(Eshed-Eisenbach and Peles, 2013).  Axonal spectrins can be rapidly proteolyzed 
following axonal injury (Buki et al., 1999), so reconstruction of these axonal domains and 
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repopulating the axon with spectrin is a key event in transitioning a regrown axon into 
a functional axon.   
Intermediate filaments 
Neuronal intermediate filaments do not provide tracks for motors, but these 
proteins have important roles in both axon function and growth.  Neuron-specific 
intermediate filaments provide structural support for growing axons, and accumulation 
of one class of filaments, the neurofilaments, dictates the final caliber of an individual 
axon (Lee and Cleveland, 1996).  The pathophysiology of some human diseases is 
accompanied by alterations in neurofilament deposition, including Amyotrophic Lateral 
Sclerosis (ALS), Alzheimer’s disease, Parkinson’s disease and several neuropathies 
(Perrot and Eyer, 2009).  Post-translational modification of the polypeptides that make 
up neurofilaments contributes to their axonal delivery (Szaro and Strong, 2010).  The 
intermittent ‘slow component’ of microtubule-based transport of neurofilaments may 
contribute to the precise deposition of intermediate filaments along the axon (Shea and 
Lee, 2013).  High levels of neurofilament mRNA and protein levels are typically 
associated with more mature axons.  In fact, synthesis of neurofilaments protein falls 
after axotomy of peripheral nerves and stays relatively lower during regeneration 
(Hoffman and Cleveland, 1988).  In some cases phosphorylated neurofilaments 
accumulate in the soma of regenerating axons, suggesting that transport into growing 
axons is reduced (Goldstein et al., 1987). 
Another type of intermediate filament protein in neurons, peripherin, is 
expressed primarily in peripheral neurons.  In contrast to neurofilament expression, 
peripherin expression increases during regenerative growth, falling back to basal levels 
as axons near their target tissues (Reid et al., 2010).  The axonal inclusions seen in some 
ALS model mice have been shown to include peripherin, and overexpression of the ALS 
linked protein TDP43 has been shown to cause a prolonged increase in peripherin 
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expression after peripheral nerve injury (Swarup et al., 2012).  This implies that the 
ALS model has an altered course of neural repair.   
Microtubules 
Microtubules are the largest of the cytoskeletal polymers, and like 
microfilaments, have intrinsic polarity and the potential to be highly dynamic.  Each 
microtubule is made of thirteen parallel protofilaments, which are polymers of α- and β-
tubulin heterodimers (Prokop, 2013).  The organization of the heterodimers imparts the 
polarity to microtubules, with the α subunit nearer the ‘plus end’ and the β subunit is 
nearer the ‘minus end’.  In axons, microtubules have uniform polarity with distal plus 
ends oriented away from the cell body, but dendrites have mixed microtubule polarity 
(Baas and Lin, 2011).  In motor based transport this polarity is important because motor 
proteins typically prefer to move in either a plus end or minus end direction (Figure 1A).  
Therefore, the polarity of microtubules creates a situation in which motors exhibit 
unidirectional movement in axons and bidirectional movement in dendrites.   
Microtubules shrink and grow due to dimer addition and loss at their plus ends 
in a process called dynamic instability (Mitchison and Kirschner, 1984).  Plus ends are 
the most dynamic, and have a cadre of associated proteins, known as ‘plus end tethering 
proteins’ (+TIPs), that regulate their behavior (Schuyler and Pellman, 2001).  Growth and 
shrinkage occurs less frequently at minus ends, in part because minus-end binding 
proteins can both protect against microtubule depolymerization as well as prevent 
addition of tubulin dimers (Goodwin and Vale, 2010).  With neural injury, the 
microtubules and neurofilamens are depolymerized in the axon near the injury site on 
the proximal side (Figure 1B).   
The importance of microtubules in axon growth has been known for decades.  
The expression of tubulins increases during regeneration, recapitulating developmental 
expression levels (Hoffman and Cleveland, 1988).  Microtubule polymerization is a 
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critical, and highly regulated process in axon growth, and drugs that inhibit 
polymerization can block axon growth in cultured neurons (Tanaka et al., 1995).  
Interestingly, stabilization of microtubules with taxol can augment spinal cord 
regeneration (Hellal et al., 2011).  Microtubule acetylation has been linked to 
microtubule dynamics and to regeneration (see below) (Cho et al., 2013).  Microtubule-
associated proteins (MAPs) also modify microtubule structure (e.g., ‘bundling’ of 
microtubules along the axon shaft), microtubule stability, and motor protein processivity 
(Hirokawa, 1994).   
The Growth Cone is Uniquely Suited for its Job 
The growing ends of developing and regenerating axons form a specialized 
structure called the ‘growth cone’ (Figure 1C).  The shape and behavior of the growth 
cone is dictated by both extrinsic and intrinsic factors (Gomez and Letourneau, 2014).  
Examples of extrinsic factors are substrate molecules in the extracellular milieu or matrix 
(ECM) present along the growth trajectory, and molecules secreted locally into the 
environment by neighboring cells.  Intrinsic factors include cytoskeletal dynamics that 
are often regulated by proteins within the growth cone like the Rho, Rac, and CD42 
small GTPases, as well as the spatial distribution of receptors for sensing environmental 
cues.  Generation of a growth cone after an axon is injured is generally thought to be 
essential for regenerative growth.  One of the initial events in establishing a growth cone 
after injury is the entrance of calcium into the damaged axon – as outlined in subsequent 
sections, this triggers a number of changes that not only allow this important structure 
to form, but also facilitates signaling to the neuronal cell body (Bradke et al., 2012). 
While growth cones can vary greatly in shape and behavior, a typical advancing 
growth cone is composed of three major domains:  central (C-), transition (T-), and 
peripheral (P-) domains (Gomez and Letourneau, 2014).  The C-domain is made up of 
stable microtubule bundles that come from the axon shaft. These microtubules tend to 
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be acetylated in the axon shaft, and as microtubules enter the growth cone, 
tyrosination becomes the prominent post-translational modification on the tubulins 
(Figure 1C).  Acetylated tubulin is associated with stable polymers, while tyrosinated 
tubulin is associated with more dynamic polymers (Janke, 2014).  The C-domain 
typically contains the more dynamic microtubules that can extend linearly in sync with 
the advancing edge of the growth cone.  However, microtubules are responsive to 
environmental cues, and can shrink back or become curved in order to pause 
advancement or to reorient direction of growth (Lowery and Van Vactor, 2009).  The P-
domain at the very leading edge of the growth cone is composed of actin-based 
projections called lamellipodia and filopodia.  Microfilaments in lamellipodia form a 
dynamic mesh, with new filaments being added to growing edge and old filaments 
being broken down at the back of the mesh near the C-domain.  Force generating 
myosin motors (see below) control the contractility of this meshwork (Medeiros et al., 
2006).  The filopodia, are fingerlike projections outward from lamellipodia that extend 
and retract to sample their environment.  They contain dynamic bundles of actin 
filaments, which are thought to form through the concerted action of myosin-driven 
‘retrograde flow’ of the actin mesh in lamellipodia, and the extension of actin polymers 
in the filopodia (Medeiros et al., 2006).  
The dynamic nature of the cytoskeleton in growth cones is what allows these 
structures to respond to environmental cues, and growth cones ultimately must 
transition into synaptic endings or other types of functional axon termini.  When the 
growth cone adheres to a substrate such as laminin, the actin cytoskeleton becomes 
anchored to receptors, preventing retrograde movement of actin, which causes the 
filopodia of the growth cone to extend or protrude via distal actin polymerization 
(Mitchison and Kirschner, 1988).  As this happens, myosin motors create tension 
between F-actin filaments and an F-actin arc at the base of the growth cone closest to the 
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axon shaft.  This allows microtubules of the C-domain to move forward, leading to an 
engorged growth cone; after this, the F-actin arc depolymerizes and the membrane 
collapses around the stable microtubule bundles, consolidating this region into an 
extension of the axon shaft (Lowery and Van Vactor, 2009).  It should be noted that 
localized synthesis of β-actin protein and actin interacting proteins in growth cones may 
also contribute to actin dynamics in the growth cone, as well as along the axon shaft 
where collateral branches form (Zhang et al., 1999, Spillane et al., 2013).  Motor protein 
regulators (e.g., Lis1 and Ndel1, see below) are prominent in growth cones of 
regenerating axons in culture (Smith et al., 2000, Niethammer et al., 2000), and can play 
an active role in promoting growth cone motility.    
Molecular Motors Ferry Cargo to and from Axons and Provide Force 
Generation for Axon Growth  
Molecular motors transport of a wide range of cargos in axons including 
organelles, vesicles, mRNA, and signaling molecules.  The mRNAs move as RNA-
protein complexes termed ‘ribonucleoproteins’ (RNPs) (Gomes et al., 2014).  Cargo may 
be deposited along axons, or trafficked anterogradely to synapses and growth cones or 
retrogradely back to the cell body.  Transport along microtubules is carried out by 
kinesins, which for the most part are plus end directed, and cytoplasmic dynein, which 
are minus end directed (Hirokawa et al., 2010).  Cytoplasmic dynein also has the 
capacity to become tethered to the cortical actin cytoskeleton within axons and growth 
cones.  The force generating heads that project into the axon away from the cortical actin 
are then able to ‘kick’ short microtubule segments, causing them to move with their plus 
ends leading (Mazel et al., 2014).  In addition to microtubule motors, axons contain 
myosin motors that ferry cargo on microfilament tracks.  While these three classes of 
motors share common features, including motor domains that require ATP, they are also 
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quite distinct with respect to molecular organization as well as motility regulatory 
mechanisms.   
Kinesin 
There are 14 classes of kinesin superfamily proteins organized in part by where 
the motor domain is located within the polypeptide (Hirokawa et al., 2009).  
‘Conventional’ kinesins in the Kinesin 1 group are heterotetramers.  Two ‘heavy chains’ 
(KHC) form a dimer with globular head domains that interact with microtubules and 
undergo force-producing conformational changes in response to ATP binding and 
hydrolysis.  KHC stalk regions contain the dimerization domains, while the C-terminal 
tails interact with ‘light chains’ (KLC) that confer cargo binding (Marx et al., 2006).  
Though the motor domains are well conserved, substantial variability in other parts of 
the heteromer, including KLCs, can confer cargo selectivity.  Kinesins move a variety of 
cargo towards axon termini, so they are critical for maintenance of mature axons and 
synapses, as well as for delivery of construction materials, receptors, adhesion proteins, 
and membranes to growing axons (Figure 1A and B).  Different kinesins in this large 
superfamily are responsible for anterograde transport of specific cargo types within 
axons.  Some of the specificity is likely derived from distinct heavy chains, but cargo-
specific transport by the same heavy chain can be modulated by associated light chains 
(Hirokawa et al., 2009). 
Dynein 
Although a few kinesins (e.g., KIFC2) may be capable of minus end directed 
transport (Hirokawa et al., 2009), the predominant minus end directed motor in axons is 
cytoplasmic dynein (Figure 1A and B).  This huge protein complex contains 12-14 
subunits and has two identical heavy chains (DHC) that form a dimer (Vale, 2003).  The 
large ring-shaped motor domains at one end of DHC are ATPases, and are the force-
generating component of the protein complex.  A stalk extending from each DHC motor 
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domain interacts with microtubules.  DHC’s stem interacts with an array of other 
‘chains’.  These include two intermediate chains, 2-3 light intermediate chains, and 3 
distinct light chains.  It is generally believed that the accessory subunits bind to adaptors 
that confer cargo specificity and/or control dynein processivity (Allan, 2011).  The 
cytoplasmic dynein holoenzyme is fairly uniform in subunit composition.  However, 
multiple genes encode related but distinct isoforms of each accessory subunit.  
Moreover, alternative splicing and posttranslational modifications can alter subunit 
composition to optimize dynein motors for different tasks (Pfister et al., 1996).  Because 
axonal dynein moves retrogradely towards the cell body, it is important for molecular 
communication between axon endings and the nucleus.  In intact axons, dynein carries 
information related to synapses and target tissues, and may convey signals that prevent 
continued axon elongation after developmental growth has ceased (Smith and Skene, 
1997).    
Myosin 
Myosin is a force-generating ATPase that underlies muscle contraction.  The 
classic muscle myosin remains tethered in place and brings about muscle contraction by 
exerting tugging forces on actin filaments.  Some myosins in neurons also function by 
exerting forces on the subcortical actin network (Figure 1C) – these are particularly 
prominent in regulation of growth cone dynamics needed for development and 
regeneration (Lowery and Van Vactor, 2009).  Other members of the myosin superfamily 
are processive and can ferry cargo, using microfilaments as transport tracks.  Some 
myosins (e.g., myosin Va) are plus end-directed, and others (e.g., myosin VI) are minus 
end-directed (Kneussel and Wagner, 2013).  Myosin transport is typically thought to 
occur over shorter distances than the long-range axonal transport associated with 
microtubule motors (i.e., at branch points, in growth cones, in synapses, etc.).     
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Regulation of Motor Proteins – Activation, Inhibition, and Cargo Selectivity 
Much of what we know about motor regulation has come from in vitro studies 
with purified proteins or cultured cells.  However, studies in neuronal cultures suggest 
that these mechanisms are likely relevant to nerve repair.  Because of their force 
generating capacities, their plethora of cargos, and the many cellular processes 
influenced by motors, a strictly enforced regulatory network must be in place to 
coordinate motor behaviors and modulate their behaviors in response to environmental 
cues and intrinsic cues.  At the most basic level, ATP must be in good supply for all 
motors to function properly.  Perhaps intuitively, mitochondrial ATP was shown to be 
the source of ATP for fast axon transport of mitochondria (Zala et al., 2013).  However, 
the source of ATP for transport of some vesicular cargos appears to be from glycolytic 
machinery directly associated with the vesicle (Zala et al., 2013).  Thus, the cargo itself 
can impact activity of the motor protein carrying it, and there is a growing 
understanding that complexes of motor proteins, scaffolds, and regulatory proteins can 
modulate motor processivity and force generation.  The selection of a motor’s cargo is in 
part regulated by cargo adaptors, proteins that bind to both the motors and to a specific 
type of cargo (Fu and Holzbaur, 2014).  An interesting new development is that 
mammalian cytoplasmic dynein is incapable of moving along microtubules in vitro in 
the absence of either cargo or cargo adaptor proteins (McKenney et al., 2014, Schlager et 
al., 2014).  It remains to be determined if this is also the case within the confines of the 
axon shaft. 
Knowledge of motor protein regulation has been advanced by studies of 
neurological disorders.  For example, mutant forms of HTT protein that cause 
Huntington's disease form aggregates in axons and dendrites that can block transport by 
motors (Lee et al., 2004).  Wild type HTT can bind directly to DIC subunits (Caviston et 
al., 2007), while an HTT binding partner HTT-associated protein 1 (HAP1) interacts with 
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KLC (McGuire et al., 2006).  Moreover, HTT is involved in linking the glycolytic 
machinery to cargo vesicles to provide a ready source of ATP for fast axonal transport 
(Zala et al., 2013).  While pathogenic HTT remains capable of interacting with motor 
complexes, it reduces motor association with microtubules through a JNK3-mediated 
phosphorylation of kinesin-1 (Morfini et al., 2009).   
Most organelles have all three classes of motors associated with them, usually 
more than one of each kind of motor.  Interactions between motors may occur via 
scaffolding systems (Fu and Holzbaur, 2014).  There is growing evidence that motors of 
one class can affect activity of other classes of motors (Ally et al., 2009, Levi et al., 2006).  
While many of these interactions have been observed, how functions are coordinated to 
regulate cargo movement in the same axons has not been extensively studied.  The 
precise trafficking of an individual cargo likely involves regulation of the stoichiometry 
of motor association, a tug of war between opposing motors of all three classes, the 
proximity of transport tracks, as well as post-translational modification of proteins and 
cargos (Fu and Holzbaur, 2014, Kardon and Vale, 2009).  Each of these mechanisms is 
operant in the mature as well as injured and regenerating axon.  One known molecular 
control mechanism involves the JNK-interacting protein 1 (JIP1) that acts as a scaffold 
protein that binds to both KHC and the dynein activator, dynactin (Fu and Holzbaur, 
2013).  JIP1 binding to KHC relieves an intramolecular autoinhibition of kinesin motor 
activity.  The dynactin subunit p150Glued competes with KHC for binding to JIP1 so that 
KHC is inactive when JIP1 is bound to p150Glued.  Kinesin dysinhibition and dynactin 
binding by JIP1 is regulated by JNK-dependent phosphorylation, which can lead to 
directional changes in movement of amyloid precursor protein-containing vesicles in 
axons (Fu and Holzbaur, 2013).  JIP1 is also responsible for directional selectivity of 
autophagosomes in axons.  Autophagosomes are retrogradely transported by dynein, 
and are presumed important for axonal maintenance and growth.  Dual mechanisms 
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appear to prevent activation of kinesin on these organelles (Fu et al., 2014).  JIP 
associates with autophagosomes through the adaptor, LC3, and LC3 prevents JIP 
binding to KHC.  
Other proteins can bind directly to motors and regulate force generation and/or 
processivity in vitro, and also impact axon transport in cultured cells.  For example, loss 
of Lis1 protein reduces retrograde transport of acidic vesicles and Lis1 overexpression 
increases speed and run lengths of retrogradely moving vesicles in axons (Pandey and 
Smith, 2011).  Lis1 seems to function with dynein to promote microtubule advance 
during growth cone remodeling and fast axon growth (Grabham et al., 2007).  During 
embryogenesis, Lis1 contributes to neuronal migration (Reiner and Sapir, 2013), and it 
interacts with two paralogous dynein binding proteins Ndel1 and Nde1 (Bradshaw et 
al., 2013).  Ndel1/Nde1 also serves as a platform for modulation of motor activity by 
post-translational modification.  Ndel1/Nde1 strengthens the Lis1 association with 
dynein and increases force production by promoting cooperation between multiple 
dynein motors (McKenney et al., 2010).  Interestingly, the neuronally-enriched kinase 
Cdk5, phosphorylates Ndel1/Nde1 (Niethammer et al., 2000).  Phosphorylation of 
Ndel1 by Cdk5 is important for dynein-dependent organelle transport in growing axons 
extended by adult sensory neurons in culture (Pandey and Smith, 2011).  Recent 
evidence suggests that Cdk5 is an important regulator of membrane vesicle dynamics in 
growth cones (Tojima et al., 2014, Hsiao et al., 2014). Other kinases that contribute to 
regulation of axonal transport have also been observed to impact regeneration.  For 
example, glycogen synthase kinase 3 (GSK-3) exerts a negative influence on axon 
transport in squid and fly axons (Morfini et al., 2002, Weaver et al., 2013).  GSK-3 has 
shown varying effects on axon regeneration, but recent work indicates that sustained 
activation of GSK-3 supports regeneration of axons in peripheral nerve (Gobrecht et al., 
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2014).  Clearly, the interplay between signals regulating axon transport and those 
regulating axon growth is complex, and just beginning to be understood. 
How extracellular stimuli regulate motor proteins is also not well understood, 
but some pathways are beginning to emerge.  For example, activation of semaphorin 
receptors along growing axons stimulates both anterograde and retrograde movement 
of axonal vesicles (Li et al., 2004) Semaphorin stimulation of distal axons shifts AMPA 
receptor subunit localization to dendrites through a coordinated retrograde signaling in 
axons and subsequent anterograde transport in dendrites (Yamashita et al., 2014).  
Neurotrophins also impact transport.  These ligands increase endosome binding to 
dynein through DIC phosphorylation, thereby stimulating retrograde transport 
(Mitchell et al., 2012).  Interestingly, neurotrophin receptors (Trks) are endocytosed in 
axons along with their ligands and can be retrogradely transported as a ‘signaling 
endosome’ that carries downstream effector kinases to the cell body (Schmieg et al., 
2014).  During development, many neuronal populations compete for binding to target-
derived neurotrophins and other trophic agents.  The neurons that do not secure an 
appropriate source of trophic support are eliminated through naturally occurring cell 
death.  Culture preparations in which the neurons’ cell body and axons are 
compartmentalized have shown qualitative differences in the response to neurotrophic 
stimulation of distal axons compared to the cell body (Campenot and MacInnis, 2004).  
This suggests that the signaling endosome conveys a signal different from Trk receptors 
endocytosed along the cell body.  
Activation of Trk receptors along the axon has been shown to modulate transport 
of RNPs into axons, with accumulation and translation of mRNAs adjacent to the 
trophic stimulus along axons (Willis et al., 2007).  Target derived NGF in sympathetic 
neurons was recently shown to coordinate transcriptional responses in the cell body 
with delivery of mRNA encoding a survival promoting protein, Bclw, to the axons 
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(Cosker et al., 2013).  Given that PNS injury results in increased expression of 
neurotrophins and other trophic factors by Schwann cells in the severed nerve stump 
(Funakoshi et al., 1993), it is intriguing to hypothesize that signaling endosomes moving 
retrogradely to the cell body would be used to coordinate anterograde delivery of 
macromolecules to the regenerating axons.  The cargos that motor proteins deliver into 
axons obviously play a role growth and regeneration.  The axon needs new cytoskeleton 
and membrane components to grow, as the severed segment of the axon distal to injury 
site undergoes Wallerian degeneration in mammals (see below).  It was also recently 
recognized that protein products of axonally transported mRNAs supports regeneration 
in the peripheral nervous system (Donnelly et al., 2013), and there is some evidence that 
this may occur after spinal cord injury as well (Willis et al., 2011).   
Neural Repair Mechanisms 
Injury Changes Axon Structure and Axonal Transport to Initiate a 
Regeneration Program 
With damage and severing of an axon, the segment distal to the site of injury (i.e., 
the portion no longer connected to the cell body) is actively degraded through Wallerian 
degeneration.  In the portion proximal to the site of injury, influx of Ca2+ from 
extracellular spaces promotes membrane sealing and locally activates proteases (Bradke 
et al., 2012).  Proteases degrade axonal proteins including cytoskeletal elements, and this 
is necessary for the initiation of axonal growth (Ziv and Spira, 1997).  The increase in 
axoplasmic Ca2+ also triggers retrograde signaling through transport mechanisms (Rishal 
and Fainzilber, 2010).  This shift in retrograde transport ultimately helps to turn on 
expression of genes that support growth (‘regeneration associated genes’ [RAGs]) and 
turn off expression of genes associated more with mature neuronal functions (Rishal and 
Fainzilber, 2010).  For example, axotomy in the peripheral nervous system increases the 
 20!
expression of growth-associated protein-43 [GAP-43] and Tα1-tubulin, but decreases 
expression of neurofilaments.  Injury to the mammalian brain or spinal cord, in contrast 
to peripheral nerves, often does not activate expression of RAGs, and this may in part, 
underlie the reduced growth capacity of mammalian CNS neurons after injury 
(Hoffman, 2010).  Many strategies to increase axon regeneration after central injuries 
have focused on altering the ‘intrinsic growth capacity’ of CNS neurons through 
changing gene expression programs (Mar et al., 2014a).  ECM glycoproteins and glial 
derived proteins in the injured brain and spinal cord also actively block axon growth, 
and overcoming these ‘roadblocks’ is often a complimentary strategy to support CNS 
neural repair (Geoffroy and Zheng, 2014). 
Some of the mechanisms that underlie the shift in retrograde axonal transport are 
known.  Axonal JNK3 is locally activated after injury, with a resulting increased 
association of a complex of JIP3 and activated JNK3 with the p150Glued subunit of dynactin, 
and increased retrograde transport of activated JNK3 (Cavalli et al., 2005).  This leads to 
activation of c-Jun in the neuronal cell body that presumably supports expression of 
genes needed for regeneration (Ruff et al., 2012).  Interestingly, JIP3 binding to KHC can 
also increase kinesin motility (Sun et al., 2011b).  It is not clear whether the JIP1-
dependent retrograde transport of autophagosomes mentioned above contributes to 
neural repair; however, it is intriguing that both JIP1 and JIP3 can coordinate 
anterograde and retrograde transport (Fu and Holzbaur, 2014).  This provides a 
powerful mechanism to coordinate transport to meet physiological needs of the neuron 
and potentially to recycle proteins between axons and cell body.   
Calcium influx coordinates the injury response 
The influx of Ca2+ into injured axons also triggers translation of locally stored 
mRNAs (Perry and Fainzilber, 2014).  These mRNAs are transported into axons as RNPs 
and it remains unclear exactly how Ca2+ influx activates translation locally in axons, but it 
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likely includes a commensurate release of Ca2+ stores from sites in axons (Vuppalanchi 
et al., 2012).  Axonal mRNAs known to be translated by increased axoplasmic [Ca2+] 
include Importin β1, RanBP1, and vimentin (Gomes et al., 2014).  These encode proteins 
that contribute to a retrograde injury signal in a complex highly-orchestrated process 
(Rishal and Fainzilber, 2010).  The newly translated Importin β1 in axons 
heterodimerizes with Importin α3 (Hanz et al., 2003).  Localized synthesis of RanBP1 
facilitates this by releasing α3 from an anterograde transport complex (Yudin et al., 
2008).  Interaction of the Importin β1/α3 complex with dynein is needed for the 
transport of proteins containing nuclear localization signal (NLS) to the nucleus.  The 
cargo of the dynein-Importin β1/α3 complex includes other proteins that are locally 
synthesized with injury (e.g., Stat3α) as well as proteins that are locally activated 
through injury-induced post-translational modifications (e.g., Erk 1/2) (Ben-Yaakov et 
al., 2012, Perlson et al., 2005).  Vimentin has been considered as a glial intermediate 
filament protein in the nervous system, but vimentin can be expressed in neurons, and 
its mRNA has been shown to localize to axons (Willis et al., 2007).  Curiously, proteolytic 
cleavage of vimentin in injured axons generates a 'scaffold peptide' for activated Erk 
1/2, a mitogen activated protein kinase (MAPK), to bind to Importin β1/α3 dimer.  This 
kinase is transported to the cell body with dynein, where it activates Elk1 (and possibly 
other) transcription factors (Perlson et al., 2005).  It is likely that such a post-
transcriptional mechanism is shared with other physiological responses of axons, since 
neurodegenerative stimuli, neuronal survival promoting stimuli, and a neurotropic 
virus are now recognized to couple events in the distal axons to cell body responses 
through translation of axonal mRNAs (Koyuncu et al., 2013, Baleriola et al., 2014, Cox et 
al., 2008, Cosker et al., 2013).  These and other studies indicate that axonal injury induces 
a localized, integrated response to shift retrograde transport towards cargos that assist 
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in mounting a regenerative response.  The full extent of these cargos has yet to be 
determined; the reader is referred to references in ‘Further Reading’ section below for 
additional information on cargos.  
Calcium influx transforms the injured axon to support regenerative growth 
Much of what we know about axonal transport and localized growth 
mechanisms has been derived from studies in cultured neurons, where events can be 
spatially and temporally monitored with high precision.  Neurons cultured from 
invertebrate organisms have provided a platform for visualizing cytoskeletal dynamics 
in growing and injured axons.  For example, the initial studies on Ca2+ signaling after 
axonal injury resulted from work in Aplysia neurons (Ambron and Walters, 1996).  The 
Ca2+ gradient that forms in these axons after injury occurs in both the proximal (intact) 
and distal (severed) segments of the injured axon, but only the proximal end undergoes 
regeneration (Ziv and Spira, 1997).  The Ca2+ dependent events including membrane 
sealing and cytoskeletal restructuring controlled by calcium-activated calpain, syntaxin, 
synaptotagmin and synaptobrevin are critical for neural repair (Bradke et al., 2012).  
Indeed, activation of calpain through a Ca2+-dependent mechanism is required for 
growth cone formation (Gitler and Spira, 2002).  Proteolysis of cytoskeletal elements in 
the cut axon results in a reorganization of microtubule polarity in Aplysia (Sahly et al., 
2006).  This may generate a ‘trap’ for capturing both anterogradely and retrogradely 
transported vesicles, which are then available to fuse with the plasma membrane for 
efficient and effective formation of a growth cone (Erez and Spira, 2008).  Work in 
vertebrate neurons indicates that activation of localized protein synthesis in the distal 
cut axon is also needed for growth cone formation (Verma et al., 2005).  Though the 
proteins synthesized were not identified, TC10 and Exoc3 mRNAs, which encode 
components needed for plasma membrane expansion, are locally translated in growing 
axons (Gracias et al., 2014).  Stimulation of mitogen-activated protein kinases (MAPKs) 
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and mammalian target of rapamycin (mTOR) converge on protein synthesis 
machinery and are needed for growth cone formation (Bradke et al., 2012).  Thus, 
localized mRNA translation supports the initial transition of an injured axon into a 
regenerating axon.  Subsequent growth of the axon requires delivery of necessary 
building blocks of cytoskeleton and membrane components, which is accomplished by 
anterograde transport of proteins, vesicles, and RNPs.  
Unexpected Roles for Proteins in Growing Axons 
Axonal functions for nuclear proteins 
With technical advancements in subcellular imaging, protein/RNA detection 
and analyses, and study of signal transduction mechanisms, previously unrecognized 
functions have been ascribed to proteins and protein networks that support neural 
repair.  For example, epigenetic regulation is now well recognized as a means to 
modulate expression of entire gene families, and there is clear potential for such 
chromatin-based modulation to contribute to neural repair (Finelli et al., 2013).  
However, recent work from two groups have uncovered intra-axonal functions for 
histone deacetylase (HDAC) proteins that are classically viewed as modifiers of 
chromatin structure and, hence, transcription.  The injury-induced Ca2+ entry into axons 
noted above produces a retrograde ‘Ca2+ wave’ that triggers exit of HDAC5 from the 
nucleus in a protein kinase C-dependent pathway. In keeping with classic functions of 
HDACs, the loss of HDAC5 from the nucleus supports expression of genes whose 
encoded proteins have roles in regeneration (e.g., c-Fos, c-Jun, KLF4, KFL5 and Gadd 
45a; see (Cho et al., 2013) and references within).  However, HDAC5 is also 
anterogradely transported into the injured axon, where it supports deacetylation of 
microtubules.  This decreases stability of microtubules in the cut axon that is needed for 
growth cone formation just proximal to the injury site.  Curiously, this anterograde 
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movement of HDAC5 only occurred after peripheral nerve injury and not after spinal 
cord injury (Cho et al., 2013), pointing to another distinction between the central and 
peripheral nervous systems with axonal injury (Cho et al., 2013).  HDAC6 protein has 
also been shown to function in axons, but inhibition of HDAC6, rather than activation, 
brings growth-promoting effects (Rivieccio et al., 2009).  For HDAC6 inhibition, this 
allows for growth on non-permissive substrates including myelin-associated 
glycoprotein and CSPGs that block axonal growth after spinal cord injury.  These 
observations suggest that HDAC5 and HDAC6 have antagonistic functions in neural 
repair.  However, HDAC6 may contribute to axon health because it facilitates the 
retrograde transport of protein aggregates for destruction in autophagosomes (Lee et al., 
2010).  It will be intriguing in the coming years to discover the mechanism of action and 
targets of these deacetylases in developing, regenerating and mature axons.  
New functions for APC, a protein associated with colorectal cancer 
Other proteins have shown multifunctionality that impacts axon development 
and likely axon regeneration.  Adenomatous polyposis coli protein (APC) is a large, 
multidomain microtubule-interacting protein initially discovered because truncating 
mutations lead to colorectal cancer in humans (Vogelstein and Kinzler, 2004).  APC has 
also been linked to axon growth through promoting microtubule polymerization (Chen 
et al., 2011).  In addition to its function as a +TIP, APC interacts with many different 
proteins including β-catenin and GSK-3β from the canonical Wnt signaling pathway 
(Clevers and Nusse, 2012).  Initial studies in fibroblasts raised the possibility that APC’s 
actions may also extend to interaction with mRNAs (Mili et al., 2008).  More recent work 
has shown that APC binds directly to more than 250 neuronal mRNAs (Preitner et al., 
2014).  Interestingly, nearly half of those mRNAs were known to localize into growing 
axons of PNS sensory neurons, including the Importin β1 and β-actin mRNAs that are 
mentioned above.  Preventing APC binding to a tubulin isoform mRNA (TUBB2B2) 
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decreased axonal levels of this mRNA and caused growth cones to shrink, which 
could significantly hamper the growth cone’s ability to interact with growth substrates 
(Preitner et al., 2014).  Though it is not clear whether APC is needed for transport or 
translation of these mRNAs (or both), the protein is perfectly positioned in the growth 
cone to serve as a scaffold concentrating mRNAs and translational machinery near the 
processive tips of microtubules.  There is work in developing neurons indicating that 
localized mRNAs accumulate along with translation factors and ribosome subunits 
adjacent to cytoplasmic tails of axon guidance receptors (Tcherkezian et al., 2010).  It will 
be interesting to see if APC also contributes to transport or translation of mRNAs in 
injured axons where localized protein synthesis is known to contribute to regeneration.    
A protein kinase that can regulate both axon regeneration and Wallerian 
degeneration 
Genetic screens in model organisms, including flies, worms, and mice, identified 
the ‘dual leucine zipper kinase’ (DLK) as regulator of both axon regeneration and 
degeneration (Tedeschi and Bradke, 2013).  DLK has also been called ‘ZPK’ in mice and 
‘Wallenda’ in Drosophila.  Loss of DLK delays degeneration of axons but also attenuates 
RAG transcription in the cell body (Shin et al., 2012a).  Activation of DLK can lead to 
downstream activation of both JNK and p38MAPK.  As emphasized above, JNK activation is 
important in neural repair, and downstream c-Jun dependent transcription activates 
expression of RAGs in the cell body after axonal injury (Shin et al., 2012a).  However, 
blocking JNK activation in severed axons distal to the injury site delays Wallerian 
degeneration, indicating dual functions for both DLK and JNK (Ferraris et al., 2013).  In 
addition to JNK’s roles in axonal transport mediated through JIPs, JNK is known to 
target microtubule binding proteins that regulate dynamic stability of these cytoskeletal 
elements, which can influence both axon formation and regeneration (Tedeschi and 
Bradke, 2013).  JNK phosphorylation triggers degradation of SCG10 (also called 
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Stathmin-2) in axons (Shin et al., 2012b).  SCG10 is a membrane bound protein that 
destabilizes microtubules (Riederer et al., 1997).  Degradation of SCG10 in the severed 
axon is linked to Wallerian degeneration, but SCG10 is rapidly replenished in the 
proximal axon segment proximal to the injury and this is needed for regeneration (Shin 
et al., 2014).  Destabilization of axonal microtubules through SCG10’s actions near the 
growth cone contributes to axon motility.  JNK is also known to phosphorylate 
microtubule-associated protein 1b (MAP1b) in axons, which conversely increases 
stability of microtubules (Chang et al., 2003).  Interestingly, the mRNA encoding a 
protein kinase that can be an intermediate between DLK and JNK, MKK7 or MAP2K7, 
localizes to proximal neurites of differentiating NIE-115 cells and primary hippocampal 
neurons (Feltrin et al., 2012).  This may provide a means to compartmentalize the 
functional outcome of JNK’s activation in growing axons, by concentrating substrates 
that differentially modify microtubule dynamics to different sites along the axon (e.g., 
growth cone for destabilization vs. axon shaft for stabilization).            
Regulation of microtubule motor proteins can directly support axon 
regeneration 
Interestingly, kinesin and dynein motors have recently been shown to have 
unexpected roles in attenuating axon growth.  The levels and/or activity of kinesin and 
dynein motors may contribute to axonal growth by providing a gauge for how much 
material the axon needs in order to grow (Albus et al., 2013).  In cultures of adult 
sensory neurons, partial depletion of kinesin and/or dynein heavy chains with siRNA 
actually increases axon length over time (Rishal et al., 2012).  Loa mice that have reduced 
levels of dynein heavy chain 1 (Dync1h1) show increased axon length in developing 
limb buds indicating that this length sensing mechanism is also relevant for axon growth 
in vivo (Rishal et al., 2012).  These data suggest that continual anterograde and 
retrograde signaling, analogous to a radar signal, contributes to axon growth rates (Kam 
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et al., 2009).  However, the cargos that are needed for this, both those carried 
anterograde into the axons and those carried retrograde back to the cell body, are not 
clear.   
Work from the Baas group using depletion of kinesins also suggested that 
localized interactions of kinesin and dynein motors could affect axon length (Liu et al., 
2010b).  They observed that partial depletion of kinesin-5 or kinesin-12 increased axon 
length in cultured neurons, but attributed this to a shift in the tractile forces along the 
distal axon to favor increased growth (Myers and Baas, 2007, Liu et al., 2010b).  They 
hypothesized that loss of either kinesin allows cytoplasmic dynein to pull microtubules 
in the opposite direction, moving more microtubules from the axon shaft into the 
growth cone, resulting in both increases in axon length and the inability of the growth 
cone to turn properly without spatial control over the microtubules in the growth cone 
(Liu et al., 2010b).  Regardless of whether this is a cargo-dependent signaling mechanism 
or localized force differentials through altered motor stoichiometry, the end result of 
decreasing motor protein activity results in the counter-intuitive effect of increasing 
axon length.  It will be of substantial interest to determine how these mechanisms can be 
integrated with the injury-dependent and regeneration-associated changes in axonal 
trafficking outlined above that are essential for repair of neural connectivity. 
Perspectives 
Despite all that has been learned of neural repair mechanisms and the potential for using 
trafficking to encourage axons to regrow after injury, even is the peripheral nervous 
system where regeneration is relatively robust, regenerating axons only progress at 1-2 
mm/day.  Thus, finding the means to increase growth rates should bring huge benefits.  
However, whether increased growth rate can be accomplished be modulating axon 
transport dynamics in vivo remains to be determined.  Interesting potential targets for 
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regulating axon growth through trafficking include the motors themselves, their 
regulatory partners, kinases, cargo adaptors, and specific cargos. 
In addition to overt axon elongation driven by growth cone advance, developing 
neurons must also undergo a different kind of axon growth even after synapse 
formation.  Small scale axon growth and  remodeling of synaptic connections occurs 
throughout adult life and underlies learning and memory, but this does not compare to 
increased length that nerves and axon tracts accomplish during growth from a late stage 
embryo to late adolescent, and is unlikely to be the mechanism underlying this 
elongation.  There is some evidence that neurons switch to a stretch-induced interstitial 
growth as organisms increase their rostral-to-caudal dimensions (Suter and Miller, 
2011).  Cultured sensory neurons have been ‘stretched’ in an attempt to model this 
process, and within limits, stretching results in increased rates of axon growth while 
maintaining electrophysiological function (Pfister et al., 2006).  The mechanisms 
underlying this increased growth are not clear, but it would seem that the axon must lay 
down more cytoskeleton and membrane or suffer compromised integrity.  Adult 
neurons also seem to tolerate this axon stretching less well than embryonic neurons, 
which could relate to age acquired cytoskeletal modifications or loss of developmental 
gene expression programs (Loverde et al., 2011).   Still the concept of stretch induced 
growth may be a promising lead for future neural repair strategies once the 
mechanism(s) can be uncovered, particularly if this might complement other growth 
promoting strategies.  
There are intersections between neural repair, axonal transport, and 
neurodegenerative mechanisms that warrant mention.  As indicated above, DLK and 
SCG10 have dual roles in regeneration and axonal degeneration.  The severed axon has 
lost its cell body source of proteins, RNPs, and organelles.  Consequently, this severed 
axon segment needs to survive on existing entities, or gather what it needs from its local 
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environment (e.g., glia).  To some extent, defects in axonal transport can result in a 
similar situation.  Reduced anterograde delivery of axonal components produced in the 
cell body and reduced transport of signals originating in distal targets can compromise 
the health of the neuron.  Indeed, transport defects can be a key factor in neurological 
diseases and mutations or depletion of motor proteins or their regulators are emerging 
as causative agents in disease.  Beyond Huntington’s disease mentioned above, defects 
in axon transport in age-related dementias such as Alzheimer’s disease (Kanaan et al., 
2013).  The distances that motor axons traverse may make them particularly vulnerable 
to transport deficits.   Consistent with this notion, a KHC mutation that disrupts 
microtubule binding has been found in patients with hereditary spastic paraplegias, 
mutations in mouse DHC lead to an ALS-like motor neuron degeneration (Fichera et al., 
2004, Ikenaka et al., 2012) and a mutation in the p150Glued dynactin subunit has been found 
in an autosomal dominant form of lower motor neuron disease (Puls et al., 2003).   
Symptoms of neurodegenerative disease including ALS have been linked to loss 
of synapses that may be initiated by ‘dying back’ of the distal axon (Adalbert and 
Coleman, 2012).  Blocking the degeneration of their axons can prevent the death of 
neurons in some neurodegenerative diseases.  For example, deletion or inhibition of 
DLK is neuroprotective in cellular and animal models of Alzheimer’s disease, 
Parkinson’s disease and glaucoma (Ferraris et al., 2013).  Expression of axonally targeted 
Ube4b-NMNAT1 fusion protein (‘Wlds’) can delay Wallerian degeneration and prevent 
neuron loss in several different animal models of neurodegeneration (Coleman and 
Freeman, 2010).  Delayed degeneration occurs because the Wlds protein maintains 
NAD+ levels in the severed axons.  Normally axons contain NMNAT2 that fulfills the 
same enzymatic function to maintain NAD+, but NMNAT2 has short a half-life and 
must be continually replenished by anterograde transport (Gilley and Coleman, 2010).  If 
transport becomes compromised, the neuron can be placed in the vulnerable position of 
 30!
losing its axon.  Intriguingly, work in ALS animal models pointed to a shift in the 
retrogradely transported cargos from ‘pro-survival’ cargos to ‘stress-related’ cargos with 
increasing severity of neurodegeneration (Perlson et al., 2009).   The similar responses in 
physical injury of the axon and neurodegenerative diseases suggest the possibility that 
neurons in both cases may be mounting, or attempting to mount, a regenerative 
response, although few studies have addressed this possibility.  Coordination of several 
signal transduction pathways and intracellular trafficking/signaling is needed to mount 
and maintain a regenerative response.  Small alterations in these pathways could 
effectively alter function, growth, and maintenance of the axon.  
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Figure 1:  Schematic of neural trafficking in mature, injured, and regenerating axons.   
A, Schematic of mature axon with proximal on left and distal on right; microtubules 
show characteristic polarity with plus ends oriented distally.  With this polarity, kinesin 
is used for anterograde transport and dynein is used for retrograde transport.  
Intermediate filaments and cortical microfilaments characteristic of the mature axon are 
not shown here.  B, With injury of the axon, the higher extracellular [Ca2+] results in Ca2+ 
influx (1) that triggers membrane sealing, proteolysis, and translation of resident 
mRNAs encoding injury-associated gene (IAG) products in axons.  Injury results in a  
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Figure 1:  Schematic of neural trafficking in mature, injured, and regenerating axons 
(continued).  shift in retrograde transport (2), including signaling proteins that are 
‘activated’ locally after injury as well as newly translated proteins encoded by the some 
of these IAG mRNAs in axons.  Transcription in the neuronal cell body is altered by this 
shift in transport resulting in increased transport of regeneration-associated gene (RAG) 
products (3) into the injured axon to support neural repair.  C, The repaired end of the 
injured axon is transformed into a growth cone that is rich in actin microfilaments and 
contains dynamic microtubules that support growth.   
! !
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CHAPTER 2: mRNAs and Protein Synthetic Machinery Localize Into 
Regenerating Spinal Cord Axons When They Are Provided a Substrate That 
Supports Growth2 
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Abstract 
 
Although intra-axonal protein synthesis is well recognized in cultured neurons and 
during development in vivo, there have been few reports of mRNA localization and/or 
intra-axonal translation in mature CNS axons.  Indeed, previous work indicated that 
mature CNS axons contain much lower quantities of translational machinery than PNS 
axons, leading to the conclusion that the capacity for intra-axonal protein synthesis is 
linked to a neuron’s intrinsic capacity for regeneration, with mature CNS neurons 
showing much less growth after injury than PNS neurons.  However, when regeneration 
by CNS axons is facilitated it is not known if the intra-axonal content of translational 
machinery changes or if mRNAs localize into these axons.  Here, we have used a 
peripheral nerve segment grafted into the transected spinal cord of adult rats as a 
supportive environment for regeneration by ascending spinal axons.  By quantitative 
fluorescent in situ hybridization combined with immunofluorescence to unambiguously 
distinguish intra-axonal mRNAs, we show that regenerating spinal cord axons contain 
β-actin, GAP-43, Neuritin, Reg3a, Hamp, and Importin β1 mRNAs.  These axons also 
contain 5S rRNA, phosphorylated S6 ribosomal protein, eIF2α translation factor, and 
4EBP1 translation factor inhibitory protein.  Different levels of these mRNAs in CNS 
axons from regenerating PNS axons may relate to differences in the growth capacity of 
these neurons, though the presence of mRNA transport and likely local translation in 
both CNS and PNS neurons suggests an active role in the regenerative process.   
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Introduction 
Transport of mRNAs into and translation within subcellular sites appears to be an 
evolutionarily conserved mechanism that polarized eukaryotic cells use to establish and 
maintain the unique subcellular domains needed for organismal development, rapid 
responses to environmental stimuli, and several aspects of cellular function (Martin and 
Ephrussi, 2009).  With the long distances that often separate synaptic terminals from the 
neuronal cell body, neurons heavily rely upon localized protein synthesis for autonomy 
of these distal reaches of their cytoplasm (Jung et al., 2012).  Early morphological studies 
indicated that ribosomes concentrate on the post-synaptic side of neurons near the base 
of dendritic spines (Steward and Levy, 1982), and dendritically synthesized proteins 
have been shown to contribute to synaptic function (Martin and Ephrussi, 2009).  
Although these initial studies failed to detect ribosomes in mature axons of the central 
nervous system (CNS), early works from several groups indicated that axons of 
invertebrate neurons and some vertebrate neurons contain mRNAs and translational 
machinery (Twiss and van Minnen, 2006).  However, arguments were posited that these 
were unique situations where neurons had not yet fully polarized in culture or had 
specialized structures and/or functionality (Kindler et al., 1997).  Nonetheless, there 
have been an increasing number of studies pointing to the protein synthetic capacity of 
growing axons, with several indicating that the locally synthesized proteins contribute 
to varying aspects of axon growth.  This has been particularly the case for neurons in the 
peripheral nervous system (PNS), which are argued to have a high intrinsic growth 
capacity and locally generated proteins that contribute to regenerative growth.  
PNS axons can spontaneously regenerate following injury, but those in the CNS 
have to be nurtured to regenerate.  Growth inhibitory molecules in the CNS are known 
to create a non-permissive environment for axonal regeneration in the injured brain and 
spinal cord (Geoffroy and Zheng, 2014).  Strategies to overcome such growth inhibitory 
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molecules have had limited success increasing regeneration by CNS axons, indicating 
the important role of the intrinsic growth capacity in determining success of CNS vs. 
PNS neurons.  Strategies to target such intrinsic growth mechanisms have increased in 
CNS regeneration research, with some providing a means to support growth in the non-
permissive environment of the injured CNS (Sun et al., 2011a, Park et al., 2008, Liu et al., 
2010a, Hellal et al., 2011).  Proteins that are locally synthesized in axons provide an 
intrinsic growth mechanism for regeneration in the PNS, both initiating retrograde 
signaling for increasing axon growth programs and acting locally to facilitate axon 
extension (Perry and Fainzilber, 2014).  Application of CNS growth inhibitory molecules 
to cultured dorsal root ganglion (DRG) neurons was shown to actively decrease axonal 
levels of β-actin mRNA that supports axon growth (Willis et al., 2007), indicating that the 
extrinsic environment that the axon encounters can alter this intrinsic growth 
mechanism of localized protein synthesis.   
The possibility that mature CNS axons might have protein synthetic capacity has 
received less attention.  Verma et al. (2005) showed that CNS axons in the adult rodent 
optic nerve have very low levels of translational machinery compared to those in the 
sciatic nerve (Verma et al., 2005).  These authors hypothesized that axonal levels of 
translational machinery is linked to their intrinsic growth capacity, with the overall 
lower growth capacity of CNS neurons predicting a lower content of the translational 
machinery that is needed for intra-axonal protein synthesis.  However, recent work 
suggests that intra-axonal translation may be activated in some mature CNS neurons 
(Baleriola et al., 2014). Here, we show that ascending spinal cord axons, which normally 
show limited regenerative potential, contain both mRNAs and translational machinery 
when they are provided the growth supportive environment of a peripheral nerve graft 
(PNG).  Moreover, the percent of mRNA containing axons for some regeneration-
associated gene (RAG) products is overall comparable to what is seen in the 
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regenerating sciatic nerve axons suggesting that mechanisms for targeting mRNAs 
into axons is retained in the CNS. 
 
Materials and methods 
Animal use and survival surgery – Sprague-Dawley rats (175-250 g) were used for all 
experiments.  Both male and female rats were used for peripheral nerve injury, while 
only female rats were used for spinal cord injury and peripheral nerve grafting.  
Isofluorane was used for anesthesia in all cases (5 % for induction and 2-3 % for 
maintenance).  For peripheral nerve injury, anesthetized rats were subjected to a 
unilateral sciatic nerve crush at mid-thigh as pervious described (Twiss et al., 2000); the 
contralateral nerve served as an uninjured (naïve) control.  Seven days after injury, these 
animals were euthanized by asphyxiation with CO2.  L4-5 dorsal root ganglia (DRGs) 
were removed for dissociated culture (see below), or removed and immersion fixed in 2 
% paraformaldehyde for 2 hours followed by overnight cryoprotection in 30 % sucrose.  
Sciatic nerves from mid-thigh were similarly immersion fixed and cryoprotected. 
To generate a ‘pre-degenerated’ peripheral nerve for grafting, tibial nerves of 
anesthetized ‘donor’ rats were cut bilaterally.  After 7 days to allow for Wallerian 
degeneration, nerves distal to the transection were harvested and used as grafts for 
‘recipient’ spinal cord transected rats.  For this, donor rats were anesthetized using 
Ketamine (60 mg/kg) and Xylazine (10 mg/kg), and pre-degenerated tibial nerve (~ 8 
mm in length) was harvested.  To prevent graft rejection recipient rats received daily 
subcutaneous Cyclosporine A (10 mg/kg) beginning 3 days prior to grafting continuing 
for 2 weeks when we changed to oral dosing (1 mg/ml in drinking water).  These 
animals also received ampicillin (200 mg/kg) and buprenorphine (0.1 mg/kg) at the 
time of surgery.  For spinal cord injury, the cord was exposed by dorsal laminectomy for 
access to the T12 segment of the cord.  A 2-3 mm complete spinal cord transection was 
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made by vacuum aspiration using a glass micropipette.  The PNG was secured to 
duramater using 10-0 suture and one end was apposed to the caudal wall of the lesion 
cavity and the distal end was left unapposed, lying on top of adjacent vertebral bodies.  
After 3 weeks, grafted rats were euthanized using intraperitoneal injection of Euthasol 
(pentobarbital sodium and phenytoin sodium) and transcardial perfusion with 2 % 
paraformaldehyde.  Graft tissues were then post fixed in 2 % paraformaldehyde 
overnight and cryoprotected in 30% sucrose solution prior to cryostat sectioning.  Grafts 
were cut longitudinally at 10 $m thickness and mounted directly on glass slides for 
staining procedures.   
Cell culture – For primary neuronal cultures, L4-5 DRG were harvested in Hybernate-A 
medium and then dissociated using type I collagenase (50 U/ml; Gibco) for 15 min at 37o 
C, 5% CO2 (Twiss et al., 2000a).  Dissociated ganglia were cultured overnight on 
laminin/poly-L-lysine coated coverslips.  For in situ hybridization (see below), 
coverslips were fixed for 15 min in buffered 2 % paraformaldehyde (Willis et al., 2007).   
RNA isolation and analyses – For isolation of RNA from DRGs, L4-5 ganglia were 
harvested and rinsed in DMEM/F12 medium with 1 x N2 supplement (Sigma), 10 % 
fetal bovine serum (Life Technologies), 2 mM L-glutamine and 80 nM of the RNA 
polymerase inhibitor 5,6-dichlorobenzimidazole riboside (Sigma).  DRGs were 
dissociated with 50 U/ml collagenase as above, gently triturated, and then pelleted at 
2500 xg for 2 min. Dissociated ganglia were then processed directly for RNA isolation 
using the RNAqueous total kit (Ambion). RNA concentration was determined using the 
Ribogreen reagent (Molecular Probes).  80 ng RNA was reverse transcribed using iScript 
(BioRad).  Digital droplet PCR was performed on a QX200 instrument (BioRad) using 
predesigned Taqman primer/probes for Reg3a, Hamp, Importin β1, and Amphoterin (also 
called Hmgb1) mRNAs (Integrated DNA Technologies).  Reg3a, Hamp, and Importin β1 
were duplexed with Amphoterin mRNA primers/probes for normalization.   
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in situ hybridization – Fluorescence in situ hybridization combined with 
immunofluorescence (FISH/IF) was used to detect and quantitate axonal mRNAs.  This 
was performed using digoxigenin (DIG)-labeled antisense, oligonucleotide probes.  
Probes were designed using Oligo 6 software (Molecular Biology Insights) and tested for 
specificity by BLASTN against GenBank for rat entries.  Antisense probes for  
β-actin, GAP-43, Neuritin (Nrn1), and Importin β1 mRNAs have been published (Willis et 
al., 2007, Merianda et al., 2013a).  Other antisense probes consisted of: Hamp (GenBank # 
NM_053469), nucleotides (nt) 150-195 and 276-322; and, Reg3a variant 1 (GenBank # 
NM_172077), nt 326-372 and 415-461.  Note that the Reg3a probes used here will also 
detect variant 2 (nt 224-270 and 313-359 in GenBank # NM_001145846).  For specificity 
control, a DIG-labeled scrambled probe was used.  Hybridization conditions were as 
previously described (Vuppalanchi et al., 2010) with minor modifications.  50 µg/ml 
probe was used for cultured neurons and 120 µg/ml was used for tissue sections.  Also, 
some probes showed higher specificity if hybridization was performed after 
immunolocalization.  In these cases, DIG-labeled probes were added to tissues after 
incubation with secondary antibodies for proteins, followed by incubation with anti-DIG 
primary and secondary antibodies.  β-actin, Nrn1, and GAP-43 probes were handled in 
this way.  In all cases, quantitation of signals (see below) was performed on tissues that 
were handled in identical fashion and only intra-probe comparisons were performed for 
any probe set.  
Primary antibodies used were:  anti-neurofilament (NF) H (1:750 for tissue and 
1:1000 for culture; Millipore) and -NFM (1:200 for tissue; Millipore), and -NFL (1:400 for 
tissue; Aves); anti-SCG10 (1:500 for tissue; Novus Biologicals); anti-DIG (1:200; Jackson 
ImmunoRes); and, Cy3-anti-DIG (1:200; Jackson ImmunoRes).  Secondary antibodies 
used were: FITC-donkey anti-chick, Cy3-donkey anti-mouse, and FITC-donkey anti-
rabbit, (1:200 for all; Jackson ImmunoRes); and, Alexa 488-goat anti rabbit (1:750; 
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Invitrogen).  All FISH/IF analyses were performed on at least three biological 
replicates per group with quantifications as outlined below.   
Immunostaining – Immunofluorescence (IF) on tissue sections was performed as 
described previously (Merianda et al., 2013a).  Primary antibodies used were:  anti-NFH 
(1:750; Millipore), -NFM (1:200; Millipore), -NFL (1:400; Aves); Y10B anti-5.8S rRNA 
(1:1000; Abcam); anti-S6PS235/S236 (1:100; Cell Signaling); anti-eIF2αPS51 and -eIF2α (1:100 for 
both; Cell Signaling); and, anti-4EBP1PT37/T46 and anti-4EBP1 (1:100 and 1:500, respectively; 
Cell Signaling).  Secondary antibodies used were:  FITC-donkey anti-chick, Cy5-donkey 
anti-rabbit, Cy3-goat anti-mouse, and Cy5-donkey anti-mouse (1:200 for all; Jackson 
ImmunoRes.); and, Alexa 488-goat anti-rabbit (1:750, Invitrogen).  All IF analyses were 
performed on at least three biological replicates per group.  
Imaging of axonal mRNA signals – For cultured DRG neurons, coverslips were imaged 
by epifluorescence using a Zeiss Axioplan inverted microscope fitted with Hamamatsu 
ORCA-ER CCD camera.  After first normalizing acquisition parameters so that any 
background signals from scrambled probes and antibody detection were not included, 
exposure matched images were acquired using SlideBook software (Intelligent Imaging 
Innovations).  Raw tiff images were used for calculating FISH signal intensities 
quantitated using ImageJ (http://imagej.nih.gov/ij/) along a 50 µm segment of mid-
axon shaft.  The higher FISH signals in cell body compared to axons, required lower 
exposure parameters such that axonal and cell body intensities are not comparable.  
Representative images of axonal segments were aligned using the Straighten plug-in for 
ImageJ. 
 Confocal microscopy was used to image tissue sections of sciatic nerve and 
PNGs.  Scanning parameters were matched between individual FISH probes for naïve 
sciatic nerve, crushed sciatic nerve and PNG (i.e., laser energy, pinhole, PMT 
gain/offset).  As with the epifluorescent imaging above, acquisition parameters were 
 51!
normalized by first imaging the scrambled probe to assign parameters that would not 
acquire any non-specific signals from the scrambled probe and fluorescent antibodies; 
scanning parameters for antisense probes were always set to below those generating 
minimal signal for the DIG-labeled scramble probe.  Imaging sequences for tissues 
consisted of acquiring a 300-400 µm segment of nerve or PNG by taking tile XYZ image 
stacks with 63X oil immersion objective (NA 1.4) for 12-15 optical planes at Z-depth of 
3.77-4.5 µm (0.29 µm interval between planes).  This XYZ tile scan sequence was 
captured at 2 locations along each nerve section.  The RG2B plug-in 
(http://rsb.info.nih.gov/ij/plugins/rg2bcolocalization.html) for ImageJ was used to 
extract RNA signals from FISH probes that overlap with axonal markers (SCG10 and 
NF) in each Z plane of the XYZ tile scans, with the extracted ‘axon-only’ signal projected 
as a separate channel.  We used several different methods to quantify the axonal FISH 
signals, with all analyses performed on the individual optical planes.  
First, to gain an estimate of relative distribution of RNA granules in axons, the 
FISH signal intensities were quantified along the length of individual axons.  For this, 
we used axons that could be optically isolated contiguously over at least 60 µm in the X 
dimension of the above XYZ tile scans.  Image J was used to quantify the intensity of 
these signal aggregates in region of interest (ROI) bins across the X axis over the length 
of the isolated axon segment.   
Second, to gain an estimate of the amount of axonal mRNA in the nerve and 
PNG, absolute signal intensity was quantified in each XY planes of the RG2B extracted 
images for axonal FISH signals.   FISH signal intensities across the individual XY planes 
were then normalized to the area that the SCG10 + NF immunoreactivity to account for 
varying amounts of axons in the nerve and PNGs between animals and experimental 
conditions.  The relative mRNA signal intensity   was averaged for all tiles in each 
biological replicate. 
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Third, to gain an estimate of the number of axons containing mRNA, we 
counted the absolute number of axons containing clear RNA granules across the 
individual optical planes of the XYZ tile scans.  Only axons of at least 40 µm in length 
across the tile scan were considered in this.  At least 50 axon  segments of each 
nerve/PNG section were scored to generate a percentage of ‘RNA containing axons’ in 
each nerve/PNG section, with 2 sections per animal to generate an average for each 
nerve/PNG.    
Statistical Analysis – Kaleidagraph software package (Synergy) was used for statistical 
analyses. One-way ANOVA was used to compare means of independent groups.  These 
included fluorescent intensities from FISH using ImageJ and percentage of axons with 
RNA granules using Volocity software.  P values of ≤ 0.05 were considered as statistically 
significant. 
Results 
Reg3a and Hamp mRNAs increase in axons after injury conditioning  –  The Fainzilber 
lab previously showed that Reg3a and Hamp mRNAs are transcriptionally regulated in 
L4-5 DRGs after sciatic nerve injury through a STAT3α-dependent mechanism (Ben-
Yaakov et al., 2012).  At a single gene level, Reg3a was seen to increase with peripheral 
nerve inflammation and after transection (He et al., 2010).  Micro-arrays of axonal RNAs 
from cultured neurons suggested the presence of these mRNAs in axons (data not 
shown), so we used FISH/IF to determine if we could visualize these mRNAs in the 
axons of cultured adult DRG neurons.  For this, we used L4-5 DRG neurons and 
compared axonal levels of Reg3a, Hamp, and Importin β1 mRNAs in naïve and 7 day 
injury-conditioned neurons.  Each mRNA was detected in growing sensory axons and 
showed granular signals by FISH analyses (Fig. 1A-C).  Using exposure matched images 
where each experiment was normalized to DIG-labeled scramble probes, axonal levels of 
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both Reg3a and Hamp mRNA were significantly increased in the 7 day injury-
conditioned compared to naïve DRG neurons (Fig. 1D and E).  Axonal Importin β1 
mRNA levels showed no significant differences between the injury-conditioned and 
naïve cultures (Fig. 1F).    
The increase in axonal Reg3a and Hamp mRNA levels could result from a shift in 
subcellular localization or an overall increase in the amount of these mRNAs available 
for localization.  Using transcript-specfic RT-ddPCR, we saw significantly increased 
levels of Reg3a and Hamp mRNAs in the L4-5 DRGs within 3 days after mid-thigh sciatic 
nerve crush injury (Fig. 2A-B).  This is consistent with previous micro-array data from 
Ben-Yaakov et al. (2012), and both mRNAs showed a trend to greater levels in the DRGs 
ipsilateral to the crush injury up to 28 days post-crush by our RT-ddPCR analyses (Fig. 
2A-B).  Importin β1 mRNA, which encodes a retrograde injury signaling protein in the 
DRGs and is translationally regulated in axons after crush injury (Hanz et al., 2003), 
showed no significant changes from naive in the L4-5 DRGs after crush injury (Fig. 2C).  
The increased transcription of Reg3a and Hamp following axotomy plus their axonal 
localization of their mRNAs suggest that the REG3A and Hepcidin proteins encoded by 
these mRNAs may contribute to axonal growth.    
Reg3a and Hamp mRNAs localize into PNS axons in vivo  –  Levels of several mRNAs 
in axons of DRG neurons have been shown to increase with injury (Gumy et al., 2011, 
Merianda et al., 2013a, Merianda et al., 2013b, Yoo et al., 2013).  The increased axonal 
localization described above for cultured neurons could indicate that injury-induced 
transcription of some RAGs is coupled to anterograde transport of their mRNAs into 
axons.  We used quantitative FISH/IF methods to determine if axonal transport of Reg3a 
and Hamp mRNAs might also increase in vivo.  In the FISH/IF studies above, Reg3a, 
Hamp, and Importin β1 mRNAs were not restricted to neurons and signals were seen in 
the non-neuronal cells of the DRG cultures (data not shown).  Since these non-neuronal 
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signals would complicate any in vivo quantitation of axonal mRNA in the nerve, we 
sought an approach to restrict our quantitation to only FISH signals that overlapped 
with the axonal markers in individual planes of confocal image stacks.  For this, we used 
post-processing with the RG2B Image J plug-in to extract the overlapping FISH signals.  
In this way, a third channel that removed any FISH signals that did not overlap with the 
immunoreactivity from NF and SCG10 formed a channel of ‘axon only’ FISH signals for 
each optical plane and tile (Fig. 3A-B).  By applying this image processing approach to 
high magnification images obtained by tile scanning, we are able to selectively visualize 
axonal RNA granules over a 300 x 400 µm segment of peripheral nerve (Fig. 3A and C).  
The resulting ‘axon only’ FISH/IF image from the sciatic nerve shown in Figure 3B 
clearly displays RNA signals that are not evenly distributed along the axon or evenly 
distributed between axons in these sciatic nerve sections.  It should be noted that RG2B 
processed image does not provide raw RNA intensity, but rather an intensity that is 
normalized for the NF + SCG10 signal intensity; thus, the ‘axon only’ FISH channel also 
provides an internal normalization parameter to account for changes in NF + SCG10 
signal intensities across the individual images of these XYZ tile scans and different nerve 
and experimental preparations.  
  Optically isolating individual axons from the XYZ stacks from the imaging 
sequences as shown in Figure 3 enabled us to visualize granular profiles for the RNA 
signals in the processed ‘axon only’ RNA channels and perform orthogonal projections 
to validate intra-axonal nature of the signals.  Granular FISH signals for Reg3a, Hamp, 
and Importin β1 mRNAs were clearly visible in optically isolated axons of both the naïve 
and crushed sciatic nerve by XYZ and YZ imaging (Fig. 4).  Moreover, both Reg3a and 
Hamp mRNAs appeared more abundant in the 7 day crush nerve compared to naïve 
nerve sections (Fig. 4 A, B, D, and E).  This initial analysis provides an in vivo correlation 
with the in vitro culture data, suggesting that levels of Reg3a and Hamp mRNAs are 
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increased in regenerating axons.  Quantitation of the intra-axonal signal intensities for 
Reg3a, Hamp, and Importin β1 mRNAs confirm this impression as detailed below (see 
Fig. 6).      
Reg3a and Hamp mRNAs localize into peripheral nerve graft axons after spinal cord 
transection  –   DRG levels of Reg3a and Hamp mRNAs were shown to increase 
following contusion of the spinal cord, despite injured central DRG branches showing 
little spontaneous regeneration after dorsal column injury (Blesch et al., 2012).  Thus, we 
asked if Reg3a and Hamp mRNAs might be transported into regenerating axons in the 
spinal cord.  For this, we used a spinal cord transection injury model coupled with 
peripheral nerve graft (PNG) that supports robust regeneration of injured sensory axons 
in spinal cord (Cote et al., 2011).  The PNG sections showed many fine and medium 
caliber axons that required a cocktail of NF and SCG10 antibodies for optimal 
visualization (Fig. 5A and C).  FISH signals for both Reg3a and Hamp mRNAs were 
clearly visible in the grafts and a proportion of the PNG FISH signals appeared to 
overlap with the NF + SCG10 signals (Fig. 5A-D).  Subtracting the non-neuronal RNA 
signals as performed above, showed clear linear profiles of high FISH signal intensity in 
the PNG sections that overlapped.   
On close inspection of the linear FISH signal arrays, it was clear that the 
distribution of the RNA signals varied across NF + SCG10 immunoreactive axons with 
focal concentrations of higher signal intensity.  Thus, we quantified the intra-axonal 
RNA signal intensity along contiguous 160 µm axon segments from the ‘axon only’ FISH 
signal channel merged with the NF + SCG10 channel in 20 µm bins across the X 
dimension.  Both Reg3a and Hamp mRNAs showed clear foci of high pixel intensity 
along the axon with peaks that varied between individual axons (Fig. 5E-F).  Importin β1 
mRNA showed axonal localization in the PNGs with approximately the same 
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distribution (data not shown).  These focal concentrations of axonal FISH signal 
intensities could represent aggregates of transported RNP granules or regions of 
translation.  Qualitative analyses of caudal spinal cord immediately adjacent to the PNG 
showed similar granular profiles of axonal mRNA FISH signals (data not shown), which 
would be consistent with transport of mRNAs from spinal cord into the PNG along 
axons.   
Axons regenerating into ascending PNG in spinal cord contain comparable levels of 
mRNAs as peripheral nerve  –  High magnification FISH/IF images from single tiles of 
the XYZ montages as in Figure 5 showed clear granular signals for Reg3a and Hamp 
mRNAs in optically isolated axons (Fig. 6A and B).  Importin β1 mRNA showed similar 
granular signals overlapping with NF + SCG10 signals in the PNG sections (Fig. 6C).  
Orthogonal YZ projections confirmed that the FISH signals for these transcripts resided 
in the axoplasm rather than in the non-neuronal cells included in optical planes from 
above or below the axoplasm (Fig. 6A-C, right hand insets).   
Since Reg3a, Hamp, and Importin β1 mRNAs localized into the axons regenerating 
into PNGs, we sought to directly compare the intra-axonal levels of these mRNAs in the 
naïve sciatic nerve, regenerating sciatic nerve, and regenerating CNS axons.  For this, we 
used Z stacks of 300 x 300 µm tile scans taken at two separate intervals along the sciatic 
nerve and PNG sections, and generated ‘axon only’ FISH channels to measure the RNA 
signal intensity.  The pixels/µm2 of FISH signal was then normalized to area of the NF + 
SCG10 signals averaged across the optical planes.  The intensities for ‘axon only’ Reg3a, 
Hamp and Importin β1 mRNA signals were not statistically different comparing naïve 
sciatic nerve, 7 d injured sciatic nerve, or 21 d spinal cord PNGs (Fig. 6 D, E, and F).  
However, Reg3a and Hamp mRNAs showed higher intensity signals in injured sciatic 
nerve compared with naïve sciatic nerve injury paralleling the observations in the DRG 
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cultures.  Reg3a and Importin β1 mRNA signal intensities trended towards being 
higher in the PNGs than in the injured sciatic nerve.   
As we had seen significant variability in RNA foci along the length of individual 
axons in Figure 5 with not all axons containing appreciable FISH signals, we determined 
the percentage of axons per montage image that contained RNA signals using the ‘axon 
only’ FISH channel merged with NF + SCG10 channel.  Only axonal segments that were 
≥ 40 µm in length across the Z stacks were assessed.  Both Reg3a and Hamp mRNAs 
showed significantly higher percentage of mRNA-containing axons in the 7d injured vs. 
naïve sciatic nerve (Fig. 6G and H).  Percentage of Reg3a mRNA-containing axons was 
also significantly more in the PNG than in the naïve nerve, but this was not the case for 
Hamp mRNA where significantly higher percentage of RNA-containing axons was seen 
in the 7 day injured sciatic nerve than in the ascending spinal cord PNG (Fig. 6H).  
Percentage of Importin β1 mRNA containing axons were not significantly different 
between the naïve sciatic nerve, 7 day injured sciatic nerve, or ascending spinal cord 
PNG (Fig. 6H). 
With this differential increase in the PNG for axons containing Reg3a vs. Hamp 
mRNAs, we asked whether the mRNAs for other RAGs known to be transported into 
regenerating PNS axons might also localize into these regenerating CNS axons.  GAP-43 
is a well characterized RAG whose transcription increases during periods of axonal 
regeneration (Van der Zee et al., 1989).  Neuritin (Nrn1) mRNA levels do not change 
overall after PNS nerve injury, but the mRNA shows increased localization into PNS 
axons after nerve crush injury (Merianda et al., 2013a).  β-actin mRNA is likely the best 
characterized axonal mRNA, and GFP transgene with the 3’UTR of β-actin shows 
increased levels in ascending spinal cord axons after a thoracic contusion injury (Willis 
et al., 2011).  We were able to detect each of these mRNAs in the PNG, and both XYZ 
and YZ projections confirmed axonal localization for GAP-43, Nrn1 and β-actin mRNAs 
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in the PNG (Fig. 7A-C).  The subtracted ‘axon only’ images showed clear granular 
FISH signals arrayed in linear profiles (Fig 7A-C, lower panels).  Similar to Figure 6, 
quantitation of signal intensities did not show significant differences between the sciatic 
nerve and PNG samples but there was substantial variability as we had seen with the 
other transcripts (Fig. 7D-F).  However, assessing the percentage of mRNA-containing 
axons as outlined above showed significant differences.  Significantly higher 
percentages of mRNA-containing axons was seen for all three mRNAs comparing the 
injured to naïve sciatic nerves and ascending spinal cord PNG to naïve sciatic nerve (Fig. 
7G-I).  The percentage of mRNA-containing axons was not significantly different 
between the PNGs and injured sciatic nerve samples for GAP-43, Nrn1, and β-actin.  
Taken together, our data indicate that axons regenerating from spinal cord into an 
ascending PNG contain RAG mRNAs that can be similar to that seen in the regenerating 
PNS.    
Axons regenerating into ascending PNG from injured spinal cord contain translational 
machinery  –  Although the ascending axons in the spinal cord PNG clearly contain 
mRNAs, the data above did not provide evidence for utilization of these mRNAs as 
templates for protein synthesis.  Thus, we asked if the PNG axons contain ribosomes 
and translation factors that would be needed to synthesize proteins.   We analyzed 
signals for phosphorylated epitope of the small ribosomal protein S6 and the 5.8S rRNA 
(using Y10B antibody) in axons of sciatic nerve and spinal cord PNGs by 
immunofluorescence.  For both antibodies, axonal and non-axonal signals were visible; 
nonetheless, the orthogonal YZ (Fig. 8, right hand insets) and subtracted ‘axon only’ 
channels (Fig. 8, lower panels) showed unequivocal intra-axonal signals.  The axon only 
channels show focal aggregates of high signal intensities in the spectral images of the 
spinal cord PNG axons (Fig. 8C and F, lower panels).  The presence of both rRNA and 
phosphorylated S6 protein suggest that translationally active ribosomes are present in 
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the sciatic nerve and spinal cord PNG axons.  The relative differences in signal 
intensity for phosphorylated S6 protein in these exposure matched images suggest that 
the regenerating axons in the sciatic nerve and PNG contain translationally active 
ribosomes.  
Translation factors have previously been demonstrated in injured PNS axons, so 
we asked if the regenerating axons in the ascending spinal cord PNGs might contain 
proteins needed for initiation of translation.  To address this, we used 
immunofluorescence for the eIF4E binding protein 1 (4EBP1) and eIF2α that are needed 
for cap dependent protein synthesis.  Both 4EBP1 and eIF2α immunoreactivities were 
detected in the axons of sciatic nerve and spinal cord PNGs (Fig. 9A-C and G-I).  Again, 
orthogonal projections and subtracted ‘axon only’ channels confirmed intra-axonal 
signals for these translation machinery proteins.  Activity of 4EPB1 and eIF2α is 
regulated by phosphorylation, with phospo-4EBP1 promoting and phospho-eIF2α 
attenuating cap-dependent protein synthesis (Raven and Koromilas, 2008).  The 
phosphorylated epitopes for eIF2α and 4EBP1 were similarly detected in the axons of 
sciatic nerve and the ascending spinal cord PNGs (Fig. 9D-F and J-L).  The subtracted 
‘axon only’ channels for phospho-eIF2α showed relatively higher signals in the naïve 
sciatic nerve compared with the 7 d crushed sciatic nerve and spinal cord PNG (Fig. 9D 
vs. E-F).  Conversely, the subtracted ‘axon only’ channels for phospho-4EBP1 showed 
relatively higher signals in the 7 d crushed sciatic nerve and ascending spinal cord PNG 
than naïve sciatic nerve (Fig 9K-L vs. J).  Taken together, these data indicate that axons 
regenerating from spinal cord into the PNG likely have capacity to utilize RAG mRNAs 
to locally generate proteins.  
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Discussion 
Several labs have now shown that developing neurons can synthesize proteins in their 
axons and have implicated these intra-axonally synthesized proteins in axon 
pathfinding (Jung et al., 2012, Baleriola and Hengst, 2015).  PNS neurons retain the 
capacity for intra-axonal protein synthesis into adulthood, and this localized mRNA 
translation is particularly robust after injury of peripheral nerves (Perry and Fainzilber, 
2014).  Although ribosomes were not visualized in mature CNS axons from early 
ultrastructural studies of hippocampus (Steward and Levy, 1982), mRNAs had been 
detected in axons of a few adult CNS neuron populations (Wensley et al., 1995, Mohr et 
al., 1991).  This suggests that some mature CNS neurons could similarly retain the 
capacity to generate proteins in their axons.  Very recent work from the Hengst lab 
demonstrated intra-axonal synthesis of rodent ATF4 protein is activated in cortical 
neurons after injection of Aβ1-42 peptide into the hippocampus (Baleriola et al., 2014).  
Our data indicate that regenerating axons from the mature spinal cord may also have 
the potential to locally generate proteins when they are provided a PNG as a permissive 
environment for growth.  The ascending spinal axons regenerating into a PNG contain 
mRNAs, ribosome constituents, and translation factors.  Interestingly, axonal 
localization for some but not all of the RAG-encoded mRNAs studied here showed that 
the proportion of mRNA-containing axons in the PNG can be comparable to that of the 
regenerating peripheral nerve. These data are the first to show that endogenous mRNAs 
can be transported into the axons regenerating within the mature mammalian spinal 
cord.   
Localization of mRNAs into ascending spinal cord PNG axons would be of little 
use without access to translational machinery for synthesis of proteins.  The localization 
of ribosome constituents and translation factors in the spinal cord PNG axons suggests 
that these axons can utilize the mRNAs to generate proteins, and the presence of 
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phospho-4EBP1 in these axons further points to capacity for cap-dependent 
translation as previously demonstrated for axons of cultured DRG neurons (Pacheco and 
Twiss, 2012).  We had previously shown that GFP protein accumulates in ascending 
spinal cord axons after SCI in transgenic mice expressing GFP mRNA that was axonally 
targeted using the 3’UTR of β-actin mRNA; this was not the case in transgenic mice 
expressing a soma-restricted GFP + γ-actin 3’UTR mRNA (Willis et al., 2011).  More 
direct evidence for translation in spinal cord axons was provided by Sinbis viral-
mediated introduction of an exogenous reporter mRNA directly into spinal cord axons 
(Walker et al., 2012a).  Together, these observations suggest that the mRNAs we 
visualized in the axons regenerating in PNGs are likely to be used for protein synthesis.   
     
Although the absolute pixel intensities for the axonal mRNA signals did not give 
significant differences between the sciatic nerve and PNG samples, the percentage of 
mRNA-containing axons did show significant increases in regenerating vs. naïve sciatic 
nerve.  For GAP-43, β-actin, and Nrn1 mRNAs, the percentage of mRNA-containing 
axons in the PNGs was comparable to the regenerating sciatic nerve, suggesting that a 
similar proportion of regenerating axons may have capacity to synthesize proteins 
encoded by these mRNAs in the spinal cord PNG.  Axonally synthesized β-actin, GAP-
43, and NRN1 proteins have been shown to increase axon growth in adult DRG neurons 
(Donnelly et al., 2013, Donnelly et al., 2011, Merianda et al., 2013a).  Each of these 
mRNAs, as well as Reg3a mRNA, showed a significantly higher percentage of mRNA-
containing axons in the spinal cord PNG than in the naïve sciatic nerve, suggesting that 
transport of these mRNAs into the regenerating PNG axons may be stimulated by 
activating growth programs in these neurons as we have seen for Nrn1 mRNA in PNS 
neurons (Merianda et al., 2013a).  However, this is clearly not the case for all axonally 
localizing mRNAs, as Hamp and Importin β1 mRNAs showed no difference in percentage 
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of mRNA-containing axons comparing the spinal cord PNG and naïve sciatic nerve.  
Hamp but not Importin β1 mRNA showed increased percentage of mRNA-containing 
axons in the crushed compared to the naïve sciatic nerve.  The increase in Reg3a and 
Hamp mRNAs in the L4-5 DRGs following sciatic nerve injury as well as the axonal 
localization of these gene products suggest they represent RAGs similar to GAP-43, 
Nrn1, and β-actin mRNAs.  Interestingly, expression of Reg3a and Hamp mRNAs after 
PNS crush injury is regulated by Stat3α that is generated locally in PNS axons shortly 
after axon crush and retrogradely transported (Ben-Yaakov et al., 2012).  The locally 
synthesized Importin β1 protein also forms a retrograde signaling complex after PNS 
axotomy (Hanz et al., 2003, Perry et al., 2012), so the comparable levels of Importin β1 
mRNA in the PNG axons vs. naïve and crushed sciatic nerve axons may point to a 
similar function in the CNS.  
Reg3a and Hamp mRNAs were reported to be transcriptionally regulated after 
PNS and CNS axotomy (Ben-Yaakov et al., 2012, Blesch et al., 2012), but neither have 
been defined as RAGs.  The coupling of increased transcription and axonal mRNA 
localization for Reg3a and Hamp mRNAs is reminiscent of the well characterized RAG 
GAP-43 mRNA (Benowitz and Routtenberg, 1997).  However, it is not clear if the 
proteins encoded by Reg3a and Hamp contribute to axon growth.  Reg3a is a member of 
the ‘regenerating islet-derived’ protein family that encode lectin-related secretory 
proteins (Zhang et al., 2003).  Reg3a has also been called ‘Pancreatitis-Associated Protein 
II’ (PAPII) as its expression is induced in the early phase of pancreatitis and the protein 
is thought to contribute to tissue repair (Honda et al., 2002, Zhang et al., 2003).  Hamp 
mRNA encodes the Hepcidin peptide; hepatocyte generated Hepicidin contributes to 
plasma iron homeostasis, but the protein is also widely expressed in brain and is 
induced by inflammatory stimuli (Wang et al., 2010, Zechel et al., 2006, Zhang et al., 
2003).  Indeed, LPS induces Hepcidin in cortical neurons cocultured with microglia, a 
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mechanism that was linked to IL-6 from microglia activating neuronal Stat3 signaling 
(Qian et al., 2014).  The post-axotomy increases in Reg3a and Hamp mRNAs could be 
triggered by inflammation, but the contributions of these proteins to axon growth will 
require further studies. 
Both transport and translation of mRNAs in axons have been shown to be 
regulated by extracellular stimuli, including stimuli that are chemotactic for axons 
(Willis et al., 2007, Tcherkezian et al., 2010, Cox et al., 2008, Walker et al., 2012b, 
Huttelmaier et al., 2005).  The varying distributions of mRNA aggregates along 
individual axons shown in Figure 5 for the PNGs was comparable to that seen in the 
sciatic nerve samples.  Previous ultrastructural analyses of myelinated PNS axons 
indicated a peri-axoplasmic distribution for ribosomes in domains spaced at 
approximately 11-35 µm intervals in extruded axoplasm preparations (Koenig et al., 
2000), which is comparable to the frequency distributions seen for mRNAs along some 
of the regenerating PNG axons (Figure 5).  More recent work has indicated that β-actin 
mRNA and the ZBP1 RNA binding protein needed for its axonal localization also 
localize to these peri-axoplasmic ribosome plaques in myelinated PNS axons (Koenig, 
2009).  Similar clustering of β-actin mRNA, ZBP1, and ribosomes has been reported for 
sites of branching along axons of cultured DRG neurons (Spillane et al., 2011, Spillane et 
al., 2013).  The immunostaining for rRNA with Y10B antibody and RP S6 in the sciatic 
nerve and PNG could represent peri-axoplasmic ribosome plaques in these axons.  
However, further studies will be needed to determine if these aggregates of mRNA and 
translational machinery represent foci of active intra-axonal translation or materials in 
transit to the growth cone.         
The transport of mRNAs into the PNG axons is modulated at level of individual 
mRNAs, similar to what we and others have previously documented for the injured and 
regenerating peripheral nerve (Gomes et al., 2014).  In cultured neurons, neonatal and 
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adult DRG neurons show different mRNA populations and can alter their axonal 
transcriptome after axotomy (Gumy et al., 2011, Taylor et al., 2009).  Growth promoting 
and growth inhibiting stimuli also alter the axon’s transcriptome (Willis et al., 2007).  
The different axonal mRNA localization between the spinal cord axons regenerating into 
the PNG and those in the sciatic nerve may relate to differences in growth capacity of 
these neurons or to stimuli in the extracellular environment that they traverse.  The 
axons regenerating into the ascending PNGs used include both central branches from 
DRGs and from spinal cord interneurons (data not shown); future studies will be needed 
to distinguish these neuronal populations at the mRNA level.  Regardless of any 
differences in localization, our data indicate that axonal transport and likely translation 
can be activated in the CNS when the axons are facilitated in their regenerative effort.  
Thus, the PNG likely provides a supportive environment for both growth and intra-
axonal translation.  The increased localization of RAG encoding mRNAs raises the 
possibility that axonal mRNA transport and/or localized translation could be targeted 
for increasing CNS axon growth and guidance towards appropriate target areas.   
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Figure 1:  Injury-conditioned DRG neurons show increased axonal levels of Reg3a and 
Hamp mRNAs in culture.   
A-C, Representative FISH/IF images for Reg3a (A), Hamp (B) and Importin β1 (C)  
mRNAs (red) and neurofilament (NF) protein (green) in the mid-axon shaft of L4-5 
DRGs cultured 7 days after sciatic nerve crush injury are shown [Scale bar = 5 µm].  
D-F, Quantitation of intra-axonal RNA FISH signals for L4-5 DRG cultures prepared 7 
days after sciatic nerve crush (injury-conditioned) vs. uninjured (naïve) is shown.  Data are 
expressed as fold change relative naïve axon signals ± SEM (N ≥ 30 axons over 3 
separate culture experiments; ** = p ≤ 0.001, NS = not significant by one-way ANOVA).  
 
 
Reg3a mRNA (red)
Neurofilament (green)
Reg3a mRNA (red), Neurofilament (green)
Hamp mRNA (red)
Neurofilament (green)
Hamp mRNA (red), Neurofilament (green)
0
5
10
15
20
25
Ax
on
al 
Re
g3
a 
m
RN
A
(fo
ld 
ch
an
ge
 re
alt
ive
 to
 n
aiv
e)
***
Naive Injury Conditioned
Naive Injury Conditioned
Ax
on
al 
Ha
m
p 
m
RN
A
(fo
ld 
ch
an
ge
 re
alt
ive
 to
 n
aiv
e)
0
1
2
3
4
5
6
***
Naive Injury Conditioned
Ax
on
al 
Im
po
rti
n 
`1
 m
RN
A
(fo
ld 
ch
an
ge
 re
lat
ive
 to
 n
aiv
e)
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
1.4 
NS
Importin `1 mRNA (red)
Neurofilament (green)
Importin `1 mRNA (red), Neurofilament (green)
5 µm
 88!
 
 
 
Figure 2:  Reg3a and Hamp mRNAs levels in DRGs are increased after peripheral nerve 
injury.   
RTddPCR results for Reg3a (A), Hamp (B), and Importin β1 (C) mRNA levels in L4-5 
DRGs at 3-28 days after sciatic nerve crush are shown.  Injured DRGs (white columns) 
are expressed as fold change relative to the contralateral, uninjured DRGs (grey 
columns).  Error bars represent ± SEM for matched L4-5 DRGs taken ipsi- and 
contralateral to the injured sciatic nerve from individual animal subjects (N= 3).  Reg3a 
and Hamp mRNAs show a significant increase in cell body levels after 3 day sciatic nerve 
injury, while there is no significant change in Importin β1 mRNA levels (* = p ≤ 0.05, ** = 
p ≤ 0.001, *** = p ≤ 0.0001, and NS = not significant by one-way ANOVA).   
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Figure 3:  Spatial distribution of Reg3a mRNA in sciatic nerve axons. 
Sequence of confocal imaging and post-processing pipeline for sciatic nerve sections that 
were used to selectively visualize mRNA in axons of nerve tissues is shown.  A, 
Representative XYZ projection from 3 x 4 tile scan (103 x 103 µm each) is shown.  This  
XYZ image was created from 12 optical planes taken across a Z distance of 3.77 µm (step 
size = 0.29 µm) as individual XYZ tiles that were stitched together into a montage.  Reg3a 
mRNA is shown in red, NF + SCG10 proteins are shown in green, and DAPI signal is 
shown in blue.  Arrows indicate axonal mRNA signal, and the dotted circle indicates 
what appears to be non-neuronal mRNA signal.  The grey box indicates the tile that is 
illustrated in B.  B, Panels 2i-iii, 6i-iii, and 10i-iii show an individual XY planes from A 
showing the sequence of post-processing to extract the ‘axon only’ mRNA FISH signals 
(2, 6 and 10 indicate Z stack position).  2i, 6i, and 10i show the original XY plane that was 
subjected to RG2B image J plugin processing.  2ii, 6ii, and 10ii show the extracted ‘axon 
only mRNA’ signal in the indicated intensity spectrum.  2iii, 6iii and 10iii show the 
extracted ‘axon only’ Reg3a mRNA signal (Intensity spectrum as ‘ii’ series) merged with 
the original NF + SCG10 (green) channels.  Arrows in the 2i-iii, 6i-iii and 10i-iii image 
sequences indicate the same axon.  C, Subtracted ‘axon only’ Reg3a mRNA signal from 
all tiles where each optical plane was individually subtracted to control for varying NF +  
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Figure 3:  Spatial distribution of Reg3a mRNA in sciatic nerve axons (continued). 
SCG10 signals is shown as an intensity spectrum.  The arrows and circle indicate the 
same regions of the montage image as highlighted in A [Scale bars: A & C = 50 µm, B = 
10 µm]. 
 
 
 
  
 
 
Figure 4:  Reg3a and Hamp mRNAs localize to PNS axons in vivo. 
Representative confocal images from naïve (A-C) and 7 d post crush injured (D-F) sciatic 
nerves are shown for Reg3a (A,D), Hamp (B,E), and Importin β1 (C,F) mRNAs.  Each 
image set for A-F shows projected XYZ (top left), corresponding orthogonal YZ 
projection (top right), and projected XYZ of subtracted ‘axon only’ mRNA signals.  The 
top image pairs for A-F show mRNA in red, NF protein in green, and DAPI in blue.  The 
subtracted ‘axon only’ panels show the RNA as an intensity spectrum as indicated.  
These XYZ projections were constructed from 8 optical planes taken at 0.29 µm Z step 
intervals.  Optically isolated axon segments across the Z stacks, where only planes 
corresponding to the axoplasm of the indicated axon (arrows) are projected in the XYZ 
panels; arrows in the YZ projections indicate the same axon [Scale bar = 10 µm]. 
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Figure 5:  Spatial distribution of axonal injury-induced mRNAs in peripheral nerve 
grafted into a transected spinal cord.  
A-D, Representative montage tile images from spinal cord ascending peripheral nerve 
graft (PNG) at 21 days post-transection and grafting are shown.  Panels A and B show 
merged Reg3a (A) and Hamp (B) mRNAs (red) merged with NF + SCG10 protein (green) 
to highlight regenerating axons and DAPI (blue) to detect Schwann cell nuclei.  Arrows 
indicate axonal RNA, while the dotted region shows RNA signals that are clearly not 
overlapping with NF + SCG10 signals.  These images were processed to subtract the 
RNA FISH signals overlapping with NF + SCG10 immunoreactivity to derive a 
subtracted ‘axon only’ channel.  Panels C and D show the XYZ projections of the 
subtracted ‘axon only’ signals in the PNG for Reg3a (C) and Hamp (D) mRNAs.  Arrows 
and dotted region correspond to those same areas highlighted in panels A and B.  The 
XYZ projections were generated from 12 optical sections taken at 0.29 µm Z step 
intervals [Scale bars = 50 µm].  
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Figure 5:  Spatial distribution of axonal injury-induced mRNAs in peripheral nerve 
grafted into a transected spinal cord (continued). 
E-F, Quantification of pixel intensity for Reg3a (E) and Hamp (F) mRNA FISH signals 
across individual axons (160 µm contiguous lengths, N=12) is shown with intensities 
considered in 20 µm bins across each axon.  Signal intensities for each axon are 
displayed in a different color.  There is substantial variation  across 160 µm length with 
‘hot spots’ of high signal intensity occurring in some axons separated by regions of 
much lower intensity. 
 
 
 
  
 
 
Figure 6:  Reg3a, Hamp and Importin β1 mRNAs show differential localization in 
sciatic nerve vs. spinal cord PNG. 
A-C, Representative confocal images of regenerating axons in an ascending spinal cord 
PNG with in situ hybridization for Reg3a (A), Hamp (B), and Importin β1 (C) mRNAs and 
immunofluorescence for NF + SCG10 proteins.  Each image set for A-C shows projected 
XYZ with mRNA (red), axonal protein (green) and DAPI signals (blue) merged on top 
left.  The corresponding orthogonal YZ projection is shown on the right.  Subtracted 
‘axon only’ mRNA signals are shown as an XYZ projection on bottom with RNA 
displayed as the indicated spectral image.  XYZ projections were constructed from 8 
optical sections at 0.29 mm Z step intervals.  Optically isolated axon segments across the 
Z stacks are indicated with arrows in the XYZ and YZ projections [Scale bar = 10 µm]. 
D-F, Quantification of relative FISH signal intensity for the subtracted ‘axon only’ 
signals for Reg3a, Hamp, and Importin b1 mRNAs is shown as indicated. Data are  
expressed as fold change compared to naïve sciatic nerve ± SEM (N ≥ 50 axons) across 3 
biological replicates (NS = not significant by one-way ANOVA). 
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Figure 6:  Reg3a, Hamp and Importin β1 mRNAs show differential localization in 
sciatic nerve vs. spinal cord PNG (continued). 
G-I, Quantification of the percentage of axons of ≥ 40 µm length that contain Reg3a, 
Hamp or Importin β1 mRNAs is shown as indicated. Error bars indicate SEM (N ≥ 50 
axons in 3 animals/group; *=p ≤ 0.05, **=p ≤ 0.001, and NS = not significant by one-way 
ANOVA). 
 
 
 
  
 
 
Figure 7:  Axonal localization of growth associated mRNAs in spinal cord axons 
regenerating into peripheral nerve grafts. 
A-C, Representative confocal images of regenerating axons in an ascending spinal cord 
PNG with in situ hybridization for GAP-43 (A), Nrn1 (B), and β-actin (C) mRNAs plus 
immunofluorescence for NF + SCG10 proteins is shown as outlined in Figure 6A-C.   
XYZ projections were constructed from 8 optical sections at 0.29 mm Z step intervals.  
Optically isolated axon segments across the Z stacks are indicated with arrows in the 
XYZ and YZ projections [Scale bar = 10 µm]. 
D-I, Quantification of relative FISH signal intensity intensities (D-F) and percentage of 
mRNA containing axons (G-I) is shown for the subtracted ‘axon only’ signals for GAP-43 
(D,G), Nrn1 (E,H) , and β-actin (F,I) mRNAs as per Figure 6D-I.  Error bars represent  
SEM (N ≥ 50 axons in 3 animals/group;*=p ≤ 0.05, **=p ≤ 0.001, and NS = not significant 
by one-way ANOVA). 
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Figure 8:  Axons regenerating into a spinal cord PNG contain components of ribosomes. 
Representative confocal images from naïve sciatic nerve (A,D), 7 d crushed sciatic nerve 
(B,E), and ascending spinal cord PNG (C, F) that were immunostained for 
phosphorylated ribosomal protein S6 (S6PS235/S236; A-C) and 5.8S rRNA (Y10B; D-F) are  
shown.  The series A-C and D-F are exposure matched images with upper row of each 
showing XYZ (left) and corresponding orthogonal YZ projections (right) of merged 
channels for S6PS235/S236 or Y10B (red), NF (green), and DAPI (blue).  Lower row of each 
image sequence shows the subtracted ‘axon only’ signals for S6PS235/S236 and Y10B.  Arrows 
in each panel represent the same axon segment that was optically isolated from non-
neuronal elements above and below the axoplasm in the planes used for XYZ projection. 
These projections were generated from 10 optical sections taken at 0.29 µm Z step 
intervals [Scale bar = 10 µm]. 
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Figure 9:  Axons regenerating into a spinal cord PNG contain eIF2α  and 4EBP1.   
Representative confocal images from naïve sciatic nerve (A,D,G,J), 7 d crushed sciatic 
nerve (B,E,H,K), and ascending spinal cord PNG (C,F,I,L) that were immunostained for  
4EBP1 (A-C) and phospho-4EBP1 (4EBP1PT37/T46; G-I), eIF2α (D-F), and phosphorylated 
eIF2α (eIF2αPS51; J-L) are shown.  XYZ and orthogonal YZ projections in upper row of each 
image sequence with 4EBP1 and eIF2α in red, NF protein in green, and DAPI signal in 
blue.  The lower row of each image sequence shows XYZ projection of subtracted ‘axon 
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Figure 9:  Axons regenerating into a spinal cord PNG contain eIF2α  and 4EBP1 
(continued). 
only’ signals for 4EBP1 and eIF2α as the indicated intensity spectrum.  Arrows in each 
panel represent the same axon segment that was optically isolated from non-neuronal 
elements above and below the axoplasm in the planes used for XYZ projection. These 
projections were generated from 10 optical sections taken at 0.29 µm Z step intervals 
[Scale bar = 10 µm].  
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CHAPTER 3: Transient HDAC6 Inhibition Alters Cytoskeleton Dynamics 
and Increases Mitochondrial Trafficking in Axons3 
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3!Ashley Kalinski, John Craver, Paul Brito-Vargas, Brett Langley, Jeffery L. Twiss. In preparation 
for submission in November 2015. 
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Abstract 
Histone deaceytlases (HDAC) have recently been shown to have roles in axon growth 
and regeneration (Rivieccio et al., 2009, Cho et al., 2013) .  HDAC6 has primarily 
cytoplasmic localization where its targets have been shown to include α-tubulin, 
cortactin, HSP90, and some polyubiquitinated proteins.  Inhibition of neuronal HDAC6 
supports axon growth on the non-permissive substrates of myelin associated 
glycoprotein (MAG) and chondroitin sulfate proteoglycans (CSPGs), but the mechanism 
underlying this effect has remained unknown.  Here, I have used Tubastatin A, a highly 
specific inhibitor of HDAC6, to begin to address the intracellular mechanisms that 
HDAC6 uses to modulate axon growth in cultures of adult rat sensory neurons.  HDAC6 
inhibited cultures showed significantly increased levels of acetylated α-tubulin in their 
distal axons with profiles of acetylated microtubules extending into the growth cones. 
Growth cones rapidly expanded after HDAC6 inhibition, with a commensurate decrease 
in F-actin in growth cones.  There was a net increase in anterograde transport of 
mitochondria after HDAC6 inhibition and numbers of mitochondria were 
approximately two fold higher in growth cones compared to control conditions.  Focal 
ablation of mitochondria using chromophore-assisted light inactivation (CALI) to target 
mitochondrial-localized Killer Red protein resulted in rapid retraction of growth cones 
under control conditions but cultures with inhibited HDAC6 showed were largely 
unaffected by the mitochondrial ablation and growth cone mitochondria were rapidly 
replenished.  These findings support the notion that transient inhibition of HDAC6 is 
neuroprotective, stabilizing distal axons and growth cones likely through altered 
cytoskeletal dynamics and increased mitochondrial trafficking.    
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Introduction 
 
An underlying cause for failed regeneration in the central nervous system is the 
presence of inhibitory proteins in the extracellular matrix such as myelin-associated 
glycoprotein (MAG), neurite outgrowth inhibitor protein (NOGO), and chondroitin 
sulfate proteoglycans (CSPGs) (Schwab et al., 2006).  NOGO and MAG are important 
players during development of the nervous system by helping to guide axons to their 
targets in the adult nervous system, these factors likely restrict excessive growth or 
sprouting of neuronal processes (for review see (Hannila and Filbin, 2008).  At the same 
time this attenuation of growth presents an inhibitory environment for regeneration of 
injured neuronal processes in the central nervous system (CNS).  MAG, CSPGs, and 
NOGO molecules share several signaling pathways including activation of the small G-
protein RhoA that causes actin depolymerization and growth cone collapse 
(Schweigreiter et al., 2004).  Inhibiting downstream activation of Rho-activated protein 
kinase (ROCK) or increasing intracellular cAMP levels by treatment with cell permeable 
non-hydrolyzable cAMP analogs enables neurons to extend axons on some non-
permissive substrates (Cai et al., 2001, Joshi et al., 2015, Fournier et al., 2003) .  
Strategies to modify microtubule dynamics in neurons have also been shown to 
support axon growth on non-permissive substrates like MAG and CSPGs.  Although 
better known for their nuclear functions, histone acetylases (HAT) and histone 
deacetylases (HDAC) can function in the cytoplasm and target numerous proteins.  The 
mammalian HDACs are divided into 4 classes based on their domain structure.  Class I 
HDACs (HDACs 1, 2, 3 and 8) are predominately nuclear and are ubiquitously 
expressed (Cho and Cavalli, 2014).  Class II HDACs shuttle between the nucleus and 
cytoplasm (IIa includes HDACs 4, 5, 7 and 9, and IIb includes HDACs 6 & 10) (Hubbert 
et al., 2002, Lahm et al., 2007).  HDAC6 localizes into neuronal processes, and inhibition 
of HDAC6 has been shown to support axon growth on MAG and CSPGs (Rivieccio et 
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al., 2009, Lin et al., 2015).  Distinct from other HDACs, HDAC6 has 2 catalytic 
domains and a C-terminal zinc finger domain (Haberland et al., 2009).  The known 
substrates for HDAC6 are primarily cytoplasmic proteins like α-tubulin (Hubbert et al., 
2002).  HDAC6 was identified as the first tubulin deacetylase, and HDAC6 knockout 
mice show hyperacetylation of α-tubulin in all tissues (Zhang et al., 2008).  Post-
translational modifications (PTMs) of tubulin can affect the function and stability of 
microtubules (Hammond et al., 2008b).  Stabilized microtubules were shown to reduce 
axon degeneration and prevent end bulb formation of CNS axons in vivo after injury 
(Erturk et al., 2007).  At some level, cell motility, differentiation and vesicle trafficking 
can be regulated by acetylation of α-tubulin on lysine 40 (Janke and Kneussel, 2010).    
Despite that several HDAC6 substrates are known to localize into axons, the 
intracellular mechanisms that HDAC6 uses to modulate axon growth have not been 
uncovered.  Lin et al. (2015) recently reported that 24 hour inhibition of HDAC6 with 
Tubacin or Tubastatin A resulted in decreased axon length on laminin.  HDAC6 was 
previously shown to have neuroprotective functions, and much shorter treatment 
durations with HDAC6 inhibitors prevented growth cone collapse in response to MAG 
stimuli  (Rivieccio et al., 2009).  Thus, I asked if tubulin acetylation status in distal axons 
and, particularly, in growth cones changes with short-term inhibition of HDAC6.  
Within 20 min after application of the HDAC6 inhibitor Tubastatin A to cultures of adult 
sensory neurons resulted, growth cones expanded.   These enlarged growth cones 
showed increased levels of acetylated α-tubulin, cortactin, and HSP90 but decreased 
levels of F-actin.  Mitochondrial transport was altered by HDAC6 inhibition and the 
organelles accumulated in growth cones. Targeted ablation of mitochondria in growth 
cones resulted in rapid axon retraction in neurons with normal HDAC6 activity, but 
inhibition of HDAC6 activity with Tubastatin A protected growth cones from retraction.  
Together these data indicate that rapid alterations in cytoskeletal dynamics and 
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mitochondrial transport may underlie the growth promoting effects of HDAC6 
inhibition.         
Materials and Methods 
 
Animal use – All vertebrate animal experiments were performed under protocols 
approved by Institutional Animal Care and Use Committees of Drexel University or the 
University of South Carolina.  Male Sprague-Dawley rats (175-250 g) were used for all 
experiments.  Animals were killed using CO2 asphyxiation per approved methods.  L4-5 
dorsal root ganglia (DRGs) were rapidly removed for dissociated culture (see below).  
Primary neuron culture – For primary neuronal cultures, L4-5 DRG were harvested in 
Hybernate-A medium (BrainBits) and then dissociated using type I collagenase (50 U/ml; 
Gibco) for 20 minutes at 37oC, 5% CO2 (Twiss et al., 2000).  Dissociated ganglia were 
cultured in complete medium containing 10% FetalPlex animal serum complex (Gemini) 
and 10 µM cytosine-arabinoside (Sigma) on laminin/poly-L-lysine coated substrates.  
18-24 hour cultures were used for immunostaining and MitoTracker experiments.  For 
transfection, neurons were cultured for 72 hours for after electroporation and plating.  
For isolation of axons and cell bodies for immunoblotting, 72 hour cultures were used.  
DRGs were cultured on glass coverslips for immunostaining, glass-bottom 35 mm dishes 
(Wilco) for live cell imaging, and porous membranes for isolation of axons and cell body 
preparations for immunoblotting.  For inhibition of HDAC6, DRG cultures were treated 
with 10 µM Tubastatin A (reconstituted in DMSO; (Rivieccio et al., 2009) for indicated 
durations.  The same concentration of DMSO was added to control cultures for all 
Tubastatin A experiments (“vehicle control”).  MitoTracker-green (Life Technologies) was 
used to visualize mitochondria in DRG cultures; this was prepared according to 
manufacturer’s instructions and used at 50 nM applied 30 minutes prior imaging 
followed by two washes in fresh medium.  
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DNA constructs and transfections – For some experiments, pABCb10aa1-35-GFP 
(Addgene) was used as a mitochondrial marker (Graf et al., 2004).  Mitochondrial 
targeted Killer Red plasmid (Mito-KR; Evrogen) was used to ablate mitochondria in 
growth cones.  For some imaging experiments, transfection with blue fluorescent protein 
(TagBFP;Evrogen) was used to visualize axons.  DRG cultures were transfected using 
the Amaxa nucleofector with basic neuron SCN nucleofector kit (Lonza).   
Immunoblotting – Axonal and cell body protein isolates from DRG cultures were 
analyzed by immunoblotting. For isolation of axons, DRGs were cultured for 72 hours 
on coated porous polyethylene tetrapthalate membrane (8.0 µm pores; Falcon) (Zheng et 
al., 2001).  Axons were isolated by carefully scraping with a cotton-tipped applicator to 
remove cell bodies from the upper membrane surface; the lower membrane surface was 
scraped with a cotton-tipped applicator to remove axons.  The severed axons and 
isolated cell body fractions were then lysed at 4°C for 20 minutes in 1% SDS, and 20% 
glycerol in 120 mM Tris.HCl [ph 6.8] with 1 x protease inhibitor cocktail (Sigma).  
Lysates were cleared by centrifugation at 15,000 × g at 4°C and normalized for protein 
content by Bradford assay.  1 µg protein lysate was denatured and processed with the 
Protein Simple Wes capillary electrophoresis/immunoblotting apparatus using the 12-230 
kDa separation kit.  Primary antibodies used were:  rabbit anti-acetylated α- tubulin 
(1:50; Cell signaling) and anti-ERK 1/2 (1:50; Protein Simple).  Secondary antibody 
consisted of horseradish peroxidase-conjugated anti-rabbit antibody (Protein Simple). 
Levels of acetylated α-tubulin were quantified by normalizing chemiluminescence 
intensity to ERK 1/2-control intensities.    
Immunostaining – Standard immunofluorescent methods were used as previously 
described (Merianda et al., 2009).  All steps were performed at room temperature unless 
specified otherwise.  Coverslips were rinsed in phosphate buffered saline (PBS), fixed in 
3.7 % formaldehyde for 15-20 minutes, and then washed twice in PBS.  Cultures were 
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permeabilized with PBS plus 0.3% Triton X100 (PBST; Sigma) for 5 minutes.  
Coverslips were blocked in 2% BSA and 2% fetal bovine serum (Gemini) for 1 hour.  For 
standard detection of axons, coverslips were incubated with mouse anti-neurofilament 
(RT97 at 1:1000; Developmental Studies Hybridoma Bank) and blocking buffer (Roche) 
overnight at 4°C in a humidified chamber.  After three washes in PBST, coverslips were 
incubated with anti-mouse FITC (1:200; Jackson ImmunoResearch) for 1 hour, then 
washed twice with PBS and distilled H20 and mounted with Prolong Gold Antifade with 
DAPI (Life Technologies).  
For detection of post-translationally modified α-tubulin, I used a sequential 
immunostaining approach to allow simultaneous detection of tyrosinated α-tubulin (by 
indirect immunofluorescence), acetylated α-tubulin, and total β-tubulin (by direct 
immunofluorescence).  Phalloidin staining was also used to detect F-actin.  After fixation 
and permeabilization, coverslips were incubated with anti-tyrosinated α-tubulin (1:100; 
Sigma) in blocking buffer (Roche) overnight at 4°C in a humidified chamber.  Cells were 
washed three times in PBST and then incubated with anti-mouse Cy5 (1:200; Jackson) in 
blocking buffer for 1 hour.  Cells were washed twice with PBST and then incubated with 
Alexa405-conjugated mouse anti-acetylated α-tubulin (1:50) and FITC-conjugated mouse 
anti-β-tubulin (Tub 2.1) (1:50; Sigma) in blocking buffer (Roche) for 1.5 hours.  The 
mouse anti-acetyl α-tubulin antibody (Sigma) was conjugated to Alexa405 using the 
Zenon Labeling Kit per manufacturer’s instructions (Life Technologies).  Coverslips 
were washed twice with PBS then stained with Actin-Alexa 555 (Life Technologies) for 
30 minutes.  After rinsing with PBS and then distilled H20, coverslips were mounted with 
Prolong Gold Antifade.    
Epifluorescence imaging was performed on a Leica DM6000 M fluorescent 
microscope fitted with a Hamamatsu ORCA R2 CCD camera.  Confocal imaging was 
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performed on a Leica SP8X fitted with a galvanometer Z stage and HyD detectors.  
All images were matched for exposure, gain, excitation power (lamp intensity or laser 
power), and post-processing sequences.  Signals for tubulin and F-actin were verified as 
axonal by matching to merged channels with differential interference contrast (DIC) 
images. 
Live cell imaging – L4-L5 DRG cultures were incubated with MitoTracker as above and 
then imaged in complete medium (without phenol red) in an environmental chamber 
maintained at 37°C, 5% CO2 on inverted platform Leica SP8X confocal microscope 
throughout the course of the imaging sequence.  Leica 40x/NA 1.3 or 63x/NA 1.4 
objectives were used for imaging.  Regions of interest (ROI) were scanned every 10 
seconds for a duration of 10 minutes each to visualize mitochondrial movement.  In 
some experiments the same cells were imaged before and after addition of Tubastatin A; 
for this, no DMSO was added to control cultures (i.e., baseline imaging) to avoid 
doubling the DMSO concentrations with Tubastatin exposure.  Potential effects of 
DMSO were assessed in separate experiments.   
  For mitochondrial ablation, DRG cultures expressing Mito-KR and BFP were 
imaged with the same confocal microscope.  In this case, ROI comprised of the entire 
growth cone region.  Mito-KR was activated with the Argon laser at 514 nm (100 % 
power) continuously for 30 seconds until there was no detectable signal.  Following 
activation, up to 50 µm of the distal axon shaft and the growth cone were imaged every 
10 seconds for 12-18 minutes using 585 nm laser lines at 13 % power (for cultures with 
BFP, 405 nm laser at 15.3% was used simultaneously).   
Image analyses – NF or β-tubulin stained cultures were used for neurite growth 
analyses.  Only neurites ≥ 100 µm were considered in these analyses and all analyses 
were performed in a blinded fashion.  Neurite length and branching was quantified 
from randomly acquired tile scans using WIS-Neuromath software package (Rishal et 
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al., 2013).  Growth cones were distinguished by visualizing the termination of the 
compacted, parallel NF positive bundles in the axon shaft by immunofluorescence and 
by formation of distinct lamellapodia characteristic of the proximal growth cone by DIC.  
Growth cone area was measured using Image J software (NIH) from these annotated 
DIC images.  
 Vesicle trafficking was quantified using differential Particle Tracking Plugin for 
Image J (NIH).  Axon segments between 50-60 µm in length were analyzed. Kymographs 
were generated with a Kymograph plugin with Image J.  For axon retraction analysis the 
distance from the distal tip of the growth cone in the pre-CALI image was used as the 
baseline.  The distal growth cone tip was subsequently marked at the end of the imaging 
sequence and the distance between the end and the baseline was measured on the 
confocal software.  Any movement greater than 0.5 µm towards the axon shaft was 
counted as “retracted”.  Recovery of Mito-KR signal was analyzed first with the Leica 
software.  Background signal was measured in Image J then subtracted from each point 
manually to give a final intensity measurement at each time point.  
Results 
Short-term HDAC6 inhibition increases growth cone size of DRG axons -The 
microtubule-stabilizing drug Taxol, has been shown to support axon growth on 
inhibitory myelin substrates (Erturk et al., 2007).  While groups have reported that 
stabilization of microtubules does not increase axon outgrowth from DRG neurons 
(Erturk et al., 2007, Lin et al., 2015), it is hypothesized to make the axon more resistant to 
inhibitory cues.  Acetylated microtubules in axons localize to regions of more stable 
microtubules (Janke and Bulinski, 2011).  Lin et al. (2015)  recently showed that 24 hour 
exposure to the HDAC inhibitors Tubacin or Tubastatin A decreased axon growth from 
DRG neurons. However, our lab had previously shown that shorter durations of 
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Tubastatin A treatment allowed axons to grow on MAG and CSPGs. Thus, I asked 
how short term inhibition of HDAC6 might alter axon growth in cultures of adult DRG 
neurons.  After overnight culture, dissociated DRGs were treated with either 10 µM 
Tubastatin A or vehicle control for one hour, a concentration that selectively inhibits 
HDAC6 (Rivieccio et al., 2009).  The Tubastatin A-exposed DRGs had dramatically 
larger growth cones than the vehicle controls (Figure 1A).  Neurite length was not 
significantly different between the Tubastatin A-treated and vehicle control DRGs 
(Figure 1B).  On the other, hand growth cone area increased by 1.76 ± 0.18 fold (p ≤ 
0.005) with one hour exposure to Tubastatin A (Figure 2B).   
Considering the above increase in growth cone area occurred within an hour of 
exposure to the HDAC6 inhibitor, I asked how quickly this change in growth cones 
occurs by live cell imaging.  Figure 1D shows that the growth enlargement initiates 
between 10 and 20 min of Tubastatin A exposure.  Sister cultures treated with the DMSO 
vehicle control showed no change in growth cone appearance over these same time 
periods (data not shown).  Taken together, these data indicate that inhibition of HDAC6 
in sensory neurons seems to initially target the distal axon or growth cone.  Consistent 
with this, both endogenous and transfected HDAC6 concentrate in distal axons of these 
cultured DRG neurons (data not shown).   
HDAC6 inhibition selectively alters cytoskeleton in distal axons - The cytoskeleton of 
growth cones is highly dynamic and this underlies the growth capabilities of the axon 
(for review see (Song and Brady, 2015)).   HDAC6 is known to deacetylate α-tubulin and 
acetylated microtubules are not typically seen in the distal portions of growing axons.  
Tyrosinated microtubules concentrate in distal axons and growth cones contain high 
levels of F-actin (Robson and Burgoyne, 1989).  Immunostaining of vehicle treated DRG 
cultures showed robust signals for F-actin in growth cones and tyrosinated α-tubulin in 
distal axon shafts, but much lower immunoreactivity for acetylated α-tubulin in these 
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structures (Figure 2A, upper row).  With one hour exposure to Tubastatin A, 
acetylated α-tubulin immuoreactivity increased in the distal axon and growth cone, 
while levels of F-actin in the growth cone appeared to fall relative to vehicle treated 
DRG cultures (Figure 2A).  Quantification of these signals over multiple experiments 
showed significantly increased acetylated α-tubulin signals and decreased F-actin 
signals in growth cones of the tubastatin A treated vs. control DRG cultures (Figure 2B).  
Acetylated α-tubulin signals in in the distal axon showed a small but not significant 
increase with Tubastatin A treatment; there was no significant change in tyrosinated α-
tubulin levels in the tubastatin A treated cultures (Figure 2B).  By capillary 
immunoblotting, the axons from the Tubastatin A treated cultures showed an 
approximately 1.8 fold increase in acetylated α-tubulin band while the cell bodies 
showed no differences between Tubastatin A and control cultures (Figure 2C).   
Confocal microscopy was used to gain a high-resolution three dimensional view 
of the distal axon and the growth cone of the above DRG cultures.  3D projections of the 
F-actin channels showed depletion of signals from the periphery of the growth cones 
treated after Tubastatin A compared to the controls (Figure 3).  The more central regions 
of the growth cone were filled with acetylated microtubules on the 3D projections of the 
acetylated α-tubulin channel (Figure 3).  Taken together, these data indicate that 
inhibition of neuronal HDAC6 activity selectively acetylated tubulin in distal axons.   
HSP90 and Cortactin show increased acetylation in HDAC6 inhibited growth cones - 
As mentioned previously, HDAC6 is cytoplasmic and as such has several other non-
histone substrates besides tubulin, including HSP90 and Cortactin (Li et al., 2013).  It has 
been shown that HDAC6 can regulate acetylation of cortactin, and inhibition of 
hyperacetylation of cortactin was show to interrupt its interaction with F-actin in non-
neuronal contexts (Zhang et al., 2007).  Using acetylated-cortactin and -HSP90 specific 
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antibodies for immunostaining, the DRG neurons appeared to have increased acetyl-
cortactin and acetyl-HSP90 immunoreactivities in distal axons and growth cones after 
one hour exposure to Tubastatin A (Figure 4A,B).  Quantification across multiple 
experiments showed a significant increase in growth cone levels of acetylated HSP90 
protein after HDAC6 inhibition (Figure 4C).  Although the images showed more 
prominent signals for acetylated cortactin protein growth cones, particularly in the 
filopodia, of the HDAC6 inhibited cultures (Figure 4B), the differences failed to reach 
statistical significance on quantification.  Nonetheless, these data point to other 
substrates for HDAC6 in the growth cones of these adult DRG neurons.  
Mitochondria accumulate in growth cones with short-term HDAC6 inhibition - With 
the alterations in acetylated microtubules in distal axons, it was possible that 
microtubule-based transport is altered in the HDAC6 inhibited neurons.  HDAC6 
inhibition has previously been shown to increase transport of mitochondria in axons of 
embryonic hippocampal neurons in culture (Chen et al., 2010, Kim et al., 2012).  Thus, I 
used live cell imaging with MitoTracker to track mitochondria movements before and 
after inhibition of HDAC6 with Tubastatin A in the adult DRG neurons (Figure 5A).  
Representative kymographs for tracks of individual mitochondria are shown in Figure 
5B and quantification across multiple culture experiments is shown in Figure 5D.  The 
representative images and kymographs suggested a net shift towards more anterograde 
movement of mitochondria at 1 hour following HDAC6 inhibition (Figure 5A-B).  
Quantification of the mitochondria kinetics showed no clear differences in the velocities 
or track durations for anterogradely vs. retrogradely moving mitochondrial profiles 
after Tubastatin A treatment (Figure 5D).  Comparing the numbers of anterogradely vs. 
retrogradely moving mitochondria showed an overall favoring of anterograde 
movement after Tubastatin A treatment (Figure 5D).  Although this did not reach 
statistical significance, there was an approximately 2 fold increase in the number of 
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mitochondria in the growth cone after Tubastatin A treatment for this same duration 
(Figure 5C).  This suggests that the net shift towards anterograde movement of 
mitochondria in axons after HDAC6 inhibition significantly changes the organelle’s 
distribution along the axons.   
HDAC6 inhibition protects axons from mitochondrial damage - I sought to determine 
the potential functional relevance of the increase in growth cone mitochondria noted 
above. For this, I turned to a chromophore-assisted light activation (CALI) technique to 
selectively ablate mitochondria from growth cones of DRG cultures expressing mito-KR 
protein.  Activation of KillerRed with green light results in increased reactive oxygen 
species (ROS) (1000x higher than from activation of eGFP fluorescent emission) (for 
review see (Sano et al., 2014)).  Targeting KillerRed protein to mitochondria  (i.e., Mito-
KR), the increased production of ROS upon photoactivation of KillerRed protein leads to 
mitochondrial damage and ablation of mitochondrial function (Shibuya and Tsujimoto, 
2012).  The Gallo lab used this technique in chick DRG neurons to show that functional 
mitochondria are needed for neurotrophin-dependent collateral branching (Spillane et 
al., 2013).  The vehicle treated cultures displayed two distinct morphologies upon 
ablation of mitochondria.  A significant majority axons retracted their growth cone 
immediately after activation of mito-KR (Figure 6A, upper row).  The remainder of the 
vehicle treated cultures showed stable growth cones post-CALI (Figure 6B, middle row), 
but neither the retracting or stable growth cones in these vehicle treated cultures 
recovered mitochondrial signals after the bleaching judged by movement of the 
fluorescent mitochondria from unbleached proximal segments of the axon (Figure 6A, 
upper and middle row insets).  Most of the Tubastatin A treated cultures showed no 
growth cone retraction after mitochondrial ablation and all showed rapid movement of 
mitochondria into the bleached ROI (Figure 6A, lower row).   Quantification of the 
mitochondrial fluorescence in growth cones (i.e., bleached ROI) before and after the 
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photoactivation or CALI showed significant recovery of fluorescent signals only in 
the HDAC6 inhibited cultures (Figure 6B). The percentage of retracting growth cones 
was significantly greater in the vehicle vs. Tubastatin A treated cultures as was the 
distance that growth cones retracted (Figure 6C).  Note that despite ~ 15% of the HDAC6 
inhibited cultures showed some growth cone retraction, the distances were small and 
significantly less than the retraction distance of the vehicle treated cultures (Figure 6D)  
Discussion 
Since HDAC6 was first shown to have targets other than histones, several groups have 
begun to elucidate signaling pathways that HDAC6 is involved in (for review see (Li et 
al., 2013).  Consistent with other reports, I have shown that inhibition of HDAC6 
increases acetylation of α-tubulin, HSP90 and Cortactin.  My data indicate that increase 
in acetylated proteins is specific to the distal axon and growth cone of adult sensory 
neurons.  The increase in growth cone size and levels of acetylated microtubules was 
surprisingly accompanied by a decrease in F-actin in the growth cone.  The growth cone 
is a site of active turnover of actin filaments, with concentration of these microfilaments  
in the more distal aspects of the growth cone extending into filopodia (Pollard and 
Borisy, 2003).  As actin is used for growth cone motility, the decrease in F-actin may 
represent an increase in the G-actin pool to provide higher motility to the growth cone.  
Along with these changes in levels and distributions of acetylated proteins, I saw a net 
increase in anterograde transport of mitochondria and protection of the distal axon from 
mitochondrial ablation upon inhibition of HDAC6.  We hypothesize that these features, 
at least in part, underlie the neuroprotective effects seen with HDAC6 inhibition.   
 Regulation of microtubule stability is necessary for neurite outgrowth 
polarization; these processes are tightly controlled through spatial regulation of the 
post-translational modifications of microtubule proteins (Witte et al., 2008).  
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Microtubules not only provide structural framework for the neuron, but also are 
involved in many cellular processes including migration (Kapitein and Hoogenraad, 
2015).  In culture, neurons display a pattern of high tubulin acetylation in the proximal 
axon, and show almost no acetylation in growth cones and dendrites (Cambray-Deakin 
and Burgoyne, 1987, Baas and Black, 1990); in vivo studies mirror these changes 
although the alignment of distal and proximal axons is more difficult to achieve with in 
vivo models (Erturk et al., 2007).  In contrast, growth cones contain more dynamic 
microtubules that are needed for proper structural modification in response to 
extracellular stimuli (for review see (Kalil and Dent, 2005).  HDAC6 protein concentrates 
in the same regions that have been shown to have low levels of acetylated microtubules, 
and we see that inhibition of HDAC6 results in a rapid increase in acetylated 
microtubules in the distal axon. 
 HDAC6 was identified as a tubulin deacetylase and overexpression of HDAC6 in 
NIH3T3 cells resulted in increased motility (Hubbert et al., 2002).  If HDAC6 is required 
for growth in neurons, I would expect to see a decrease in axon length with the HDAC6 
inhibitor Tubastatin A.  Interestingly, I found that inhibition of HDAC6 had no effect on 
axon growth of DRG neurons on permissive substrates despite the significantly higher 
levels of acetylated α-tubulin in their growth cones compared to controls.  Regenerating 
PNS axons have a highly organized microtubule network. In contrast, injured CNS 
axons most often form an endbulb with highly disorganized microtubules, which seems 
to be a hallmark of regenerative failure (Erturk et al., 2007).  In my studies, Tubastatin A 
treated DRG neurons showed large, splayed out growth cones that were filled with 
acetylated microtubules.  Since HDAC6 inhibited axons have been shown to grow on 
non-permissive substrates (Rivieccio et al., 2009), we hypothesize that the change in 
growth cone structure could prevent end bulb formation when HDAC6 inhibited 
neurons are presented with an inhibitory substrate.   
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 HDAC6 is restricted to the cytoplasm and in fibroblasts it is localized to the 
leading edge in actin enriched membrane ruffles (Gao et al., 2007).   Cortactin is 
localized to active sites of membrane remodeling including growth cones and is a 
known substrate of HDAC6 (Zhang et al., 2007).  HDAC6 deacetylates cortactin, which 
increases its affinity for F-actin and this promotes cell motility  (Wu et al., 1991, Zhang et 
al., 2007).  Here, I have shown that Tubastatin A increases cortactin acetylation above 
that of the controls, specifically in axonal growth cones. Subsequently I showed a 
decrease in F-actin levels in these same growth cones, which could be an effect from the 
disrupted interaction between cortactin and F-actin.   
 Acetylated HSP90 is a known substrate for HDAC6 (Bali et al., 2005, Kovacs et 
al., 2005, Murphy, 2005), and my data show increased signals for acetylated HSP90 in 
growth cones after HDAC6 inhibition.  HSP90 is chaperone protein that plays a role 
protein degradation so it consequently affects many signaling pathways (for review see 
(Neckers and Ivy, 2003).  Gao et al. (2007) showed that both HDAC6 and HSP90 are 
recruited to membrane ruffles in fibroblasts, and both proteins are required for efficient 
Rac1 activation and cell motility in response to growth factor stimulation.  
Hyperacetylation of HSP90 is thought to reduce its function (Scroggins et al., 2007, Yang 
et al., 2008).   The increase in acetylated HSP90 in growth cones that we see here could 
decrease chaperone activity of HSP90 with reduction of Rac1 activity.  Rac1 promotes 
lamellipodia and filopodia formation and axon extension through actin polymerization 
(Huber et al., 2003).  It will be of interest to see if Rac1 activity is reduced in these 
HDAC6 inhibited growth cones as they still display large lamellipodia and filopodia 
protrusions, suggesting that Rac1 and probably CDC42 are still active.         
 The increased acetylation of HPS90 and cortactin in growth cones after HDAC6 
inhibition points to other substrates for this deacetylase in axons.  Recent work from the 
Cavalli lab has pointed to another HDAC protein contributing to axon regeneration 
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pathways (Cho and Cavalli, 2012, Cho et al., 2013).  HDAC5 also deacetylates 
tubulin and does so in an injury dependent manner in PNS neurons (Cho and Cavalli, 
2012).  In contrast to HDAC6, injury-induced activation and axonal localization of 
HDAC5 is needed for PNS axon regeneration.  CNS injury does not appear to activate 
HDAC5 to the same extent, and the protein remains in its normal nuclear locale after 
optic nerve injury.  It is not clear how inhibition of HDAC6 and activation of HDAC5 
both support regeneration but share acetylated tubulin as a substrate.  Different kinetics 
of activation could underlie these disparate effects (i.e., HDAC5 early in regeneration 
and HDAC6 later on presentation of inhibitory CNS substrates).  However, it is 
appealing to hypothesis that the two HDACs have distinct substrates in axons that 
underlie their seemingly disparate functions.  
 Neurons are highly compartmentalized cells whose functions rely on active 
transport and communication between the cell body and neurites.  Transport along 
axons and dendrites is provided by the microtubule-dependent motor proteins, kinesin 
and dynein.  Molecular motor proteins read the ‘tubulin code’ taking cargos to their 
appropriate destination with some showing preference for stable and others for dynamic 
microtubules (for review see (Hammond et al., 2008a).  For example, Kinesin-1 
preferentially binds to stable microtubules, with hyperacetylation leading to redirection 
of JIP-1 cargo transport from a specific subset of neurites to all neurites (Reed et al., 
2006).  HDAC6 directly interacts with dynein through its dynein binding domain (DBM) 
to retrogradely transport polyubiquitinated proteins to the aggresome (Kawaguchi et al., 
2003).  Other recent reports have focused the effects of HDAC6 on vesicle transport 
(Chen et al., 2010, Dompierre et al., 2007, Kim et al., 2012).  This has been of interest to 
the neurodegeneration field, where axon transport defects are implicated in disease 
pathophysiology (for review see (Perlson et al., 2009).  Inhibition of HDAC6 has been 
shown to overcome mitochondria transport defects in hippocampal axons in 
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Alzheimer’s and Huntington’s disease models (Kim et al., 2012, Dompierre et al., 
2007).  Axonal transport is also of high interest for neural repair.  Mar et al. (2014) 
showed that axonal transport of mitochondria was increased in the central branch of 
DRG neurons following peripheral conditioning lesion, but not after spinal cord injury.  
This peripheral conditioning lesion has been shown to support axon growth after spinal 
cord injury (Neumann and Woolf, 1999).  I have shown that mitochondria transport can 
be increased in cultured DRG neurons within one hour of HDAC6 inhibition.  It will be 
of value to see if injection of Tubastatin A into the spinal cord after injury can also 
increase mitochondria transport, especially since these axons show increased transport 
even after mitochondrial damage (discussed below).    
 There have been several recent reports analyzing HDAC6’s role in regulating 
mitochondrial functions (Kamemura et al., 2012, Lee et al., 2014, Bai et al., 2015).  Mouse 
embryonic fibroblasts (MEF) from HDAC6 knockouts show reduced activity of 
mitochondrial respiratory complex II and citrate synthase, which is at least partly 
mediated by HSP90 (Kamemura et al., 2012).  Depletion of HDAC6 by siRNA in A375.S2 
melanoma cells induces an ROS-mediated apoptosis through likely through effects on 
mitochondria (Bai et al., 2015).  This suggests HDAC6 a potential therapeutic target for 
cancer, but my and other work in neurons raises the question of how HDAC6 can be 
neuroprotective.  Is this a unique feature of post-mitotic, highly polarized cells or could 
the physiological setting determine the outcome of HDAC6 inhibition.  Interestingly, 
HDAC6 knockout mice do not show any mitochondrial defects (Zhang et al., 2008), so 
the setting of neoplasia may be unique.  
Fusion and fission of mitochondria are important morphological changes 
activated during certain stress conditions (Lee et al., 2014).  Damaged mitochondria are 
eliminated by mitophagy, and this has been shown to be facilitated by HDAC6 
(Narendra et al., 2008, Lee et al., 2010).  Upon glucose starvation, HDAC6 knockout 
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MEFs generate higher mitochondrial ROS and are unable to undergo fusion to 
relieve this oxidative stress (Bai et al., 2015).  Mitochondrial fusion requires activation of 
MFN1, which is deacetylated by HDAC6, but HDAC6’s catalytic activity does not 
appear to be required for this (Bai et al., 2015).  It has also been shown that HDAC 
inhibitors can increase mitochondrial fusion under non-stressed conditions and this is 
independent of HDAC6 (Lee et al., 2012).  However, transient inhibition in primary 
neurons could affect mitochondrial fusion/fission dynamics compared to HDAC6 
knockout MEFs, and this needs to be evaluated.    
Peroxiredoxins (PRK-1/-2) are also known substrates of HDAC6, and they 
function to eliminate H202 (Parmigiani et al., 2008).  Interestingly, acetylation of PRK -1/-
2 increase their reducing activity (Parmigiani et al., 2008).  Rivieccio et al. (2009) showed 
inhibition of HDAC6 for 24 hours was sufficient to protect cortical neurons from 
oxidative stress conditions.  My data also point to a neuroprotective effect from HDAC6 
inhibition and this could be through growth cone stabilization.  It will be of keen interest 
to determine how the alterations I have seen here are impacted by the presentation of 
inhibitory substrates like MAG or CSPGs.    
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Figure 1:  HDAC6 inhibition increases growth cone size but not neurite length. 
A, Quantification of total neurite length for DRG axons. Data are expressed as fold 
change to vehicle ± SEM (N ≥ 95 neurons across 3 independent experiments; NS = not 
significant by one-way ANOVA).  
B, Growth cones of DRG neurons cultured on laminin and treated with HDAC6 
inhibitor (Tubastatin A) or DMSO (Cnt) for 1 hour. [Scale bar = 5 µm].  
C, Quantification of growth cone area expressed as fold change to vehicle ± SEM (N ≥ 26 
neurons over at least 3 independent experiments; ** p ≤ 0.0005 by one-way ANOVA with 
Bonferroni post-hoc analysis].  
D, Time-lapse imaging sequence of a single axon from larger tiled image after addition 
of Tubastatin A. Black arrows indicate growth cone [Scale bar = 10 µm].  
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Figure 2:  HDAC6 inhibition alters the distribution of acetylated α-tubulin and F-
actin in distal axons. 
A, DRG neurons cultured on laminin and treated with HDAC6 inhibitor Tubastatin A, 
(Bottom) or DMSO (Vehicle, Top) for 1 hour.  Neurons were stained for β-tubulin, F-
actin, tyrosinated alpha-tubulin and acetylated α-tubulin (grey). Far right panel is 
displaying F-actin (grey) and acetylated α-tubulin (red spectral) where we can see 
increased acetylated-α tubulin in the growth cone with Tubastatin A treatment. 
Arrowheads indicate distal part of growth cone [Scale bar = 5 µm].   
B, Quantification of levels of F-actin (left), tyrosinated α-tubulin (middle) and acetylated 
α-tubulin (right) from exposure matched images. Yellow bars (Tubastatin A) are 
displayed as fold change to grey bars (vehicle) ± SEM (N ≥ 17 neurons, * p ≤ 0.05; NS = 
not significant by one-way ANOVA with Bonferroni post-hoc analysis].   
C, Representative digital immunoblot for acetylated α-tubulin (left blot) and ERK 1/2 
(right blot) for axonal DRG lysates (left blots) or total DRG lysates (right blots) treated 
with either vehicle or Tubastatin A for 1 hour.  
D, Quantification of optical density of acetylated α-tubulin from axonal (left) and total 
(right) DRG lysates normalized to the loading control ERK 1/2 and expressed as fold 
change to vehicle (N = 1 independent experiment).  
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Figure 3: 3D reconstruction of growth cones from control and HDAC6 inhibited 
DRGs  
A-B, 3D reconstruction of growth cones from DRG neurons cultured on laminin and 
treated with DMSO (Vehicle, A) or HDAC6 inhibitor (Tubastatin A, B). Neurons were 
stained for acetylated α-tubulin (green) and F-actin (red).  The increase in acetylated α-
tubulin and decrease in F-actin staining with Tubastatin A treated neurons can be seen 
in plot profiles (right). F-actin (top) and Acetylated α-tubulin (bottom) are displayed as a 
red spectrum [Scale bar = 10 µm].  
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Figure 4:  HDAC6 inhibition increases acetylation of cortactin and HSP90 in growth 
cones. 
A-B, DRG neurons cultured on laminin and treated with HDAC6 inhibitor (Tubastatin 
A, Bottom) or DMSO (Vehicle, Top) for 1 hour.  Neurons were stained for neurofilament  
(green), acetylated HSP90 or acetylated Cortactin (red spectral) (A, and B, respectively). 
Far right panel is displaying neurofilament (green) and acetylated HSP90 or acetylated 
Cortactin (red) (A, and B, respectively) where we can see increased acetylated 
proteins.in the growth cone with Tubastatin A treatment.  White arrows indicate distal 
edge of the growth cone.  
[Scale bar = 10 µm].   
 C-D, Quantification of immunoreactivity for acetylated HSP90 (C) or acetylated 
Cortactin (D) Yellow bars (Tubastatin A) are displayed as fold change to grey bars 
(vehicle) ± SEM (N ≥ 10 neurons, ** p ≤ 0.005; NS = not significant by one-way ANOVA 
with Bonferroni post-hoc analysis].  
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Figure 5:  HDAC6 inhibition alters mitochondrial transport in axons. 
 A, Representative time-lapse imaging sequence of an axon stained with MitoTracker 
(grey), before (left panels), immediately after (middle panels) and 1 hour (right panels) 
after treatment with Tubastatin A. Blue lines indicate mitochondria moving in the 
anterograde direction and yellow lines indicate mitochondria moving in the retrograde 
direction (Distal axon is to the right and cell body is to the left).  This is a 1-minute 
sequence taken from the full 10 minute time-lapse, images were taken 12 seconds apart. 
[Scale bar = 10 µm].   
B, Representative kymographs from full-length movies in (A) before (left), immediately 
after (middle) and 1 hour after Tubastatin treatment (right).  Horizontal scale is distance 
(10 µm) and vertical scale is time (10 min).  Lines moving to the right indicate 
anterograde moving mitochondria, lines moving to the left indicate retrogradely moving 
mitochondria and straight lines indicate no movement.   
C, Quantification of the number of mitochondria in axonal growth cones expressed as a 
fold change to control  ± SEM.  Vehicle control (light grey); Tubastatin A (dark grey) [N 
≥ 13 axons across 3 independent experiments; * p ≤ 0.05 by one-way ANOVA with 
Bonferroni post-hoc analysis].  
D, Quantification of mitochondria velocity (left), track duration (middle) and percentage 
of moving mitochondria (right) are shown for anterograde (blue) and retrograde (yellow  
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Figure 5:  HDAC6 inhibition alters mitochondrial transport in axons (continued) 
bars) moving mitochondria ± SEM. [N = 13 axons across 3 independent experiments; NS 
= not significant by one-way ANOVA with Bonferroni post-hoc analysis].  
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Figure 6: HDAC6 inhibition protects axons from mitochondria damage. 
A, Representative images from CALI time-lapse. Axons are visible with soluble blue 
fluorescent protein (BFP, blue) and mitochondria in red (Mito-KR, red). Dotted region 
indicates growth cone. Growth cone mitochondria (red) can be seen in inset. Pre-CALI is 
image taken before activation of Mito-KillerRed. Post-CALI shows images selected at 0, 
7.5 and 15 minutes following 30-second continuous light activation. Top, retracting 
vehicle control axons; Middle, non-retracting vehicle control axons; Bottom, non-
retracting Tubastatin A treated axons [Scale bar = 10 µm]. 
B, Recovery of Mito-KR red fluorescence in growth cones of axons from CALI 
experiments . Vehicle treated axons are shown in black and Tubastatin A treated axons 
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Figure 6: HDAC6 inhibition protects axons from mitochondria damage (continued). 
in red [Error = SEM, N ≥ 13 axons from 3 independent experiments; * p ≤ 0.05; ** p ≤ 
0.005 by one-way ANOVA with Bonferroni post-hoc analysis for Tubastatin A vs. 
Control; # p ≤ 0.05; ## p ≤ 0.005 by one-way ANOVA with Bonferroni post- hoc analysis 
for Tubastatin A vs. t=0. Control vs. t=0 was not significant at any time points]. 
C, Percent of retracting growth cones from vehicle (grey and Tubastatin A (blue) treated 
axons (right), and average distance retracted (left). [Error = SEM; N ≥ 13 axons from 3 
independent experiments; * p ≤ 0.05; ** p ≤ 0.005 by one-way ANOVA with Bonferroni 
post-hoc analysis]  
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CHAPTER 4: DISCUSSION 
The notion that the axon can act independent of the cell body has helped our 
understanding of how axons respond to injury and to extracellular stimuli.  Some of the 
mechanisms of axon regeneration in the peripheral nervous system (PNS) have been 
elucidated.  A general consensus is that there is an initial localized response to initiate 
growth and signal injury in the axon followed by a slower response in the cell body that 
sustains regeneration.  If this occurs in injured axons of the central nervous system 
(CNS) has not been tested, largely because the CNS does not spontaneously regenerate 
after injury.  The work described in Chapter 2 took advantage of the regeneration 
competent peripheral nerve grafted into the injured spinal cord; this allowed me to 
directly compare axon intrinsic regeneration responses in PNS and CNS.  Chapter 3 
exploited recently available histone deacetylase (HDAC) inhibitors to gain a greater 
mechanistic understanding of how extrinsic environment can impact axon intrinsic 
growth programs.  Together with work from other laboratories, my studies indicate that 
if intrinsic growth programs can be activated in CNS axons, then axon regeneration can 
occur.  In the paragraphs below, I will highlight the relevance of my thesis work in the 
context of current knowledge in the field.  I will also briefly suggest areas for advancing 
investigations of these mechanisms that may lead to new therapeutic targets for 
improving axon regeneration in the CNS.   
 
Impact of extrinsic factors on intrinsic growth capacity 
 
Localized protein synthesis contributes to axon growth – Early ultrastructural studies 
detected polyribosomes at the base of dendritic spines in the dentate gyrus of adult rats.  
It was hypothesized that proteins generated in these dendrites contribute to synaptic 
plasticity (Steward and Levy, 1982).  Work from many different groups has 
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subsequently proven this hypothesis (for review see (Holt and Schuman, 2013)).  On 
the other hand, this original work from (Steward and Levy, 1982) did not detect 
ribosomes in the mature mammalian hippocampal axons.  Early studies using cultured 
hippocampal neurons suggested that protein synthesis machinery and mRNA are 
limited to the initial axon segment (i.e., the “axon hillock”) (Steward, 1997). 
If axons were not capable of synthesizing proteins locally as initially 
hypothesized, then these cytoplasmic extensions or processes must rely on proteins 
transported from the cell body or transferred from surrounding non-neuronal cells.  It is 
clear that both of these mechanisms help to support the axon, but several lines of 
evidence now show that the initial hypothesis that Steward posited is wrong.  An early 
metabolic labeling study by Guiditta et al. (1968) using giant squid axons showed 
incorporation of radioactive amino acids into the protein fraction of the axoplasm and 
this was blocked with protein synthesis inhibitor cyclohexamide.  Their work suggested 
that protein synthesis occurs in this axon and active polyribosomes were later isolated 
from the from squid giant axon (Giuditta et al., 1991).  It was subsequently shown that 
these polyribosomes were inherent to the axon and definitively not transferred from 
surrounding glial cells (Sotelo et al., 1999).  Similar studies in the mollusks Lymnaea 
stagnalis and Aplysia and the snail Helisoma also argued for the presence of ribosomes in 
invertebrate axons (van Minnen et al., 1997, Sheller and Bittner, 1992, Davis et al., 1992).  
However, it was suggested that these invertebrate neurons were not completely 
polarized as occurs in most vertebrate neurons, so the invertebrate axon was more a 
hybrid of an axon with dendritic characteristics. Nonetheless, there were isolated reports 
of ribosomes in axonal growth cones of developing neurons (Bunge, 1973) and 
myelinated PNS axons (Zelena, 1970).  Extruded axoplasm from goldfish Mauthner 
axons was also shown to contain ribosomes based on an electron microscopy (EM) 
technique that enhanced detection of phosphates (Koenig, 1979, Koenig and Martin, 
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1996).  Further, mRNA for odorant receptors and olfactory marker proteins were 
found in axons of rat olfactory neurons (Wensley et al., 1995), and oxytocin mRNA was 
detected in hypothalamic axon terminals in the rodent posterior pituitary gland (Mohr 
et al., 1991, Mohr and Richter, 1992).  Still it was suggested that these are unique types of 
neurons and this RNA localization was not the norm.  For the goldfish, incomplete 
axonal-dendritic polarization was posited and for the olfactory and hypothalamic 
systems no ribosomes were detected by EM in these axons.  Ultimately, these and other 
early studies were thought to not be reflective of most mature vertebrate, let alone 
mammalian, axons. 
Cortical neurons are known to establish axonal-dendritic polarity in culture, with 
one of the initial neurites committing to an axon displaying more rapid growth than the 
other neurites (Craig and Banker, 1994).  Using cultures of chick embryonic cortical 
neurons, Bassell et al. (1998) showed that developing axons contain polyribosomes and 
β-actin mRNA.  This was previously shown in cultured rat hippocampal neurons and 
mouse retinal ganglion neurons (Kleiman et al., 1994, Brittis et al., 2002), both of which 
have to be prepared from embryonic or newly born animals.  So it became clear that 
axons of developing mammalian neurons synthesize proteins, but the question of 
whether mature mammalian neurons retained the capacity for axonal protein synthesis 
remained.  Work from the Twiss lab provided evidence that intra-axonal protein 
synthesis could be ‘reactivated’ in mature PNS neurons as they regenerate their axons.  
Zheng et al. (2001) showed that axons of injury-conditioned DRG neurons, which 
robustly regenerate in vitro, contain mRNAs, rRNA, and translation factors.  They 
further showed that anucleated axons synthesize proteins and treating those isolated 
axons with a protein synthesis inhibitor caused rapid growth cone retraction (Zheng et 
al., 2001).  These data plus work from the Holt lab using retinal ganglion cell axons 
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(Campbell and Holt, 2001) unequivocally demonstrated that under certain 
conditions, axonal protein synthesis occurs and has a function(s).   
Since 2001, there has been increasing evidence that locally synthesized proteins 
in mammalian axons serve a variety of functions (for review see (Deglincerti and Jaffrey, 
2012)).  Several studies have now profiled axonal mRNA populations in different 
neuronal subtypes and in response to injury and extracellular stimuli (Willis et al., 2007, 
Taylor et al., 2009, Zivraj et al., 2010, Gumy et al., 2011). Interestingly, there is substantial 
overlap between the mRNA populations in the axons of sensory, hippocampal, and 
retinal ganglion neurons.  The number of mRNAs known to localize into axons has also 
steadily increased as detection methods advanced.  Indeed, a recent next generation 
sequencing approach (i.e., ‘RNA-Seq’) suggested that a few thousand mRNAs can be 
detected in the peripherally projecting axons of embryonic DRG neurons (Minis et al., 
2014). 
 
Axonal protein synthesis in the central nervous system – β-actin mRNA was one of the 
first recognized localizing mRNAs. β-actin mRNA also localizes to the leading edge of 
migrating fibroblasts (Singer et al., 1989, Sundell and Singer, 1991) and it is locally 
translated in axonal growth cones in response to guidance cues (Zhang et al., 1999).  
Turning growth cones show asymmetric localization and translation when guidance 
cues are applied to one side of the growth cone (Leung et al., 2006, Yao et al., 2006).  β-
actin mRNA contains a cis-acting ‘zipcode’ element in its 3’UTR that binds to the trans-
acting RNA binding protein, ZBP1, which is responsible for its localization into 
subcellular compartments including axons (Kislauskis et al., 1994, Farina et al., 2003).  
Willis et al. (2011) generated transgenic mice expressing a diffusion-limited GFP reporter 
mRNA with the 3’UTR of β-actin mRNA (GFPmyr3’β-actin) under control of the neuronal-
specific Tα1 promoter; peripheral nerves of these mice contain GFP mRNA in their 
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axons and generate GFP protein.  Interestingly, expression of this exogenous 3’UTR 
of β-actin mRNA decreased axonal localization of endogenous β-actin and GAP-43 
mRNAs, and decreases axon regeneration after sciatic nerve injury (Donnelly et al., 
2011).  The decrease in axonal levels of endogenous β-actin and GAP-43 mRNAs was 
from a competition for binding to limited levels of ZBP1 (Donnelly et al., 2013, Yoo et al., 
2013).  These and other data emphasize the importance of localized mRNA translation 
for PNS nerve regeneration (Perry and Fainzilber, 2014), but the literature suggested that 
this does not occur in mature CNS axons.   
In addition to the observations from Steward and Levy (1982), James Fawcett’s 
group showed that mature CNS axons have significantly lower levels of translational 
machinery than PNS axons (Verma et al., 2005).  Cultured adult DRG neurons rapidly 
form a growth cone after an in vitro axotomy, and this is blocked by inhibition of protein 
synthesis.  However, axotomized cultures of adult retinal ganglion cells were not 
affected by protein synthesis inhibitors when they did form growth cones, suggesting 
that PNS and CNS neurons use different mechanisms for responding to injury (Verma et 
al., 2005).  Verma and colleagues interpreted these disparate requirements for intra-
axonal protein synthesis in PNS vs. CNS neurons as representing the lower intrinsic 
capacity of CNS vs. PNS neurons.  Still the question of what happens when a mature 
CNS neuron can regenerate its axon remains unknown.  Thus, in my thesis studies I 
asked the question whether mRNAs and translational machinery localize into CNS 
axons when they are encouraged to regenerate.   
 
Methods to facilitate CNS axon regeneration  –  It is well established that CNS axons do 
not spontaneously regenerate after injury as seen in injured peripheral nerves.  CNS 
injury induces the formation of a glial scar, which is thought to protect the blood brain 
barrier from further damage (Bush et al., 1999).  This scar is a dense meshwork of 
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astrocytes that become hypertrophic after injury and increase expression of glial 
fibrillary acidic protein (GFAP) (Yang et al., 1994).  Within 24 hours of injury, these 
astrocytes begin to synthesize and secrete chondroitin sulfate proteoglycans (CSPGs) 
into the injury site (Jones et al., 2003).  This creates a physical and chemical barrier to 
axon growth.  When axons come into contact with the glial scar, they form a dystrophic 
end bulb structure, which is a hallmark of regeneration failure (Davies et al., 1999).  
Other barriers to axon growth in the CNS include proteins from the disintegrating 
myelin sheathes of severed axons as well as other growth repulsive molecules in the 
white matter of the injured CNS (Schwab and Bartholdi, 1996).  For the injured spinal 
cord and white matter tracts, axons that do grow beyond the glial scar would encounter 
these inhibitory substances in white matter where distal axons have degenerated.   
Under some circumstances, CNS axons can be encouraged to grow and the 
inhibitory extracellular environment can be partially overcome.  For example, priming 
DRG neurons with a peripheral axotomy (i.e., a sciatic nerve crush) prior to a dorsal 
column spinal cord injury increases the capacity of the DRGs to regenerate in the spinal 
cord (Neumann and Woolf, 1999).  The same effect is seen with increasing intracellular 
levels of cAMP in sensory neuron cell bodies by injection of cell-permeable, non-
hydrolyzable cAMP analog (dbcAMP) into dorsal root ganglion (DRG) (Neumann et al., 
2002, Qiu et al., 2002).  This increase in cAMP levels in sensory neurons is also seen 
following sciatic nerve injury, and embryonic neurons, whose axon growth is not 
inhibited by CNS white matter molecules outlined above, have inherently higher cAMP 
levels than adult neurons (Mukhopadhyay et al., 1994, Cai et al., 1999, Qiu et al., 2002).  
Still, the effect of conditioning or cAMP elevations is not complete and it appears that 
more is needed to coax CNS neurons to have robust axon regeneration that could lead to 
meaningful levels of functional recovery.  
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Other approaches have directly targeted the inhibitory environment that the 
glial scar presents.  The strongly growth-inhibitory glycosaminoglycan (GAG) side 
chains of CSPGs can be removed through the use of a bacterial enzyme chondroitinase 
ABC (ChABC) (Zuo et al., 1998, Bradbury et al., 2002, Garcia-Alias et al., 2008, Houle and 
Cote, 2013, Zhao and Fawcett, 2013).  Injecting ChABC in vivo into the injured spinal 
cord increases axon growth beyond glial scar and increases axon sprouting in both 
injured and spared axons (Barritt et al., 2006).  However, similar to the conditioning 
lesion and dbcAMP treatment, the chondroitinase reagent is more successful in 
combination with other treatments (Zhao and Fawcett, 2013).   
As noted above, immature neurons have higher intrinsic growth capacity than 
mature CNS neurons (Cai et al., 2001).  Several investigators have capitalized upon this 
difference by grafting stem cells into the injured spinal cord.  Neural stem cells (NSC) 
and neural precursor cells (NPC) are quite promising in they have the potential to 
restore synaptic connections and replace lost neurons and glia (Lu et al., 2014).  Lepore 
and Fischer (2005) used NSC and NPC from rats expressing an alkaline phosphatase 
transgene.  This enabled them to trace any axons stemming from the stem cells and 
unequivocally distinguish axons of the grafted cells from host axons.  With embryonic 
day 14 fetal spinal cord NSCs and NPCs, Lepore and Fischer documented axonal 
outgrowth for approximately 5 mm into the injured spinal cord beyond the injury cavity 
(Lepore and Fischer, 2005).  Transplanted neuronal and glial restricted precursor cells 
(NRPs and GRPs, respectively) were further shown to survive, differentiate into CNS 
neurons, and migrate out of the lesion site of the injured spinal cord similar to the NSC 
experiments.  The embryonic NRPs derived from spinal cord show reduced expression 
of the protein tyrosine phosphatase-σ (PTPσ) and leukocyte common antigen-related 
phosphatase receptors (LAR).  PTPσ and LAR have been shown to signal growth 
inhibitor functions of CSPGs, so the axon growth from these embryonic NRPs would not 
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be affected by CSPGs like adult neurons (Ketschek et al., 2012).  GRP in these grafts 
also appeared limit to formation of the glial scar by preventing CSPG and GFAP 
expression upregulation (Hill et al., 2004).   
Recent work from two groups has shown that host axons form synapses with 
neurons derived from the grafted stem cells.   For the NRP/GRP work in the Fisher lab, 
ascending host sensory axons from the injured spinal cord connect with neurons 
generated from the grafted precursor cells that in turn extend axons rostrally to reach 
the dorsal column nuclei (Bonner et al., 2011).  Work from the Tuszynski lab using stem 
cells that are caudalized in their commitment to neural differentiation generated a 
similar ‘relay circuit’ by grafting into the injured spinal cord (Lu et al., 2012).  However, 
in this case they focused on reconnecting cortico-spinal tracts that could restore motor 
function.  For both cases, gradients of neurotrophic factors were established in the cord 
along tracts distal to the injury to guide axons from the stem cell-derived neurons 
(Bonner et al., 2011, Lu et al., 2012).   
The above investigations with stem cells are quite promising and their success 
helps to emphasize what has been learned about failed regeneration in the injured spinal 
cord and brain.  The connectivity of host axons with neurons derived from the stem cells 
also implies that the graft itself is supportive of axon growth.  Ketschek et al. (2012) 
previously showed that conditioned medium from GRP cultures increased the 
likelihood that axons of DRG cultures would cross into growth inhibitory CSPG 
substrates.  To initially address potential mechanisms of this increased growth, I 
collaborated with the Fischer group to assess axonal mRNA levels in cultured DRG 
neurons exposed to GRPs and NRPs. These pilot studies point to increased axonal levels 
of several growth associated mRNAs including GAP-43, neuritin, and Hamp mRNAs in 
DRG neurons cocultured with NRPs and GRPs (Figure 1).  This suggests that GRPs and 
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NRPs might positively modulate axonal transport of mRNAs encoding proteins that 
support axon regeneration. 
 
Peripheral nerve grafts support axon regeneration in the injured spinal cord – In Chapter 
2, I collaborated with John Houle’s lab to use peripheral nerve grafts (PNG) to support 
regeneration of injured ascending spinal cord axons.  Since the 1980’s, several groups 
have shown that adult CNS axons will grow long distances through peripheral nerve 
grafts because of the permissive environment in the PNS  (David and Aguayo, 1981, 
Houle et al., 2006, Cote et al., 2011).  Importantly, it was observed that only regenerating 
axons enter the PNGs and not sprouts from spared axons, thus enabling the study of 
regenerating CNS axons (Friedman and Aguayo, 1985).  Obviously, the donor (PNS) 
axons in these PNGs undergo Wallerian degeneration. Bands of Büngner in the 
degenerated PNG provide cylinders of laminin that physically guide and support the 
growth of axons through the graft (Cote et al., 2011).  Transplants of Schwann cells into 
the spinal cord are also supportive of regeneration and they myelinate regenerating host 
axons (Biernaskie et al., 2007, Hill et al., 2006).  Activation of Schwann cells after 
transplantation and in the PNGs increases production of neurotrophic factors (e.g., NGF 
and BDNF) that enhance axon growth (Cote et al., 2011).   
For the work described in Chapter 2, the PNGs provided a technical advantage 
in addition to supporting axon regeneration.  Specifically, the use of the PNGs enabled 
me to test regenerating CNS axons for mRNA and translational machinery content and 
directly compare levels to axons regenerating in the periphery.   
 
Approaches to visualize and quantify mRNAs in axons  – In Chapter 2, I described 
fluorescent in situ hybridization (FISH) as a means to detect and quantify mRNAs in 
PNS and CNS axons in tissue sections.  The traditional molecular biology approaches of 
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Northern blotting and, more recently, target specific RT-PCR have enabled the study 
of gene expression through quantitative analysis of mRNA levels (Martone et al., 1998).  
However, these do not provide the spatial resolution to analyze subcellular mRNAs in 
mixed cellular populations in vivo, as I needed for analyses of axonal mRNAs.  in situ 
hybridization techniques bring the advantage of subcellular resolution, but many of the 
available methodologies suffer from low sensitivity.  
There have been many types of hybridization probes used to detect mRNAs in 
neurons (for review see (Jensen, 2014).  For example, work that the Twiss lab 
collaborated on visualized Importin-β1 mRNA in sciatic nerve using radioactive probes 
and emulsion to detect silver grains (Hanz et al., 2003).  However, axonal localization 
was just suggested by the results and the accumulated data from other approaches was 
needed to support the conclusion for intra-axonal Importin-β1 mRNA.  The Singer lab 
(and later Bassell lab) advanced the field for analyses of localized mRNAs.  Singer et al. 
(1989) used DNA probes (≤ 200 nucleotides) labeled with multiple biotins to cover the 
full length of β-actin mRNA.  Coupling anti-biotin antibody and a secondary colloidal 
gold-conjugated antibody allowed them to distinguish populations of β-actin mRNA 
that overlapped with cytoskeletal proteins by EM in cultured fibroblasts.  Bassell et al. 
(1994) advanced this approach by generating synthetic digoxigenin (DIG)-labeled 
oligo(dT) probes (55 nucleotides) that could be detected with fluorescent anti-DIG 
antibodies.  The shorter probes afforded better penetration into cells and fluorescent 
detection brought the ability to combine with immunofluorescent methods to detect 
proteins (FISH/IF).  In a subsequent landmark study, Bassell et al. (1998) used this 
approach to show that β-actin mRNA localizes to axonal growth cones while γ-actin 
mRNA is restricted to the cell body of cortical neurons.  This same differential 
localization of β-actin and γ-actin mRNAs has subsequently been documented in PNS 
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neurons, both in culture and in vivo (Zheng et al., 2001, Donnelly et al., 2011, Willis et 
al., 2011).   
 
Fluorescent in situ hybridization optimized for axons in vivo  – While we had the 
‘Bassell-Singer’ FISH/IF approach working well for cultured neurons, our group and 
others had struggled with signal-to-noise ratios to detect axonal mRNAs in tissues.  
There were several reasons why this might have been the case.  First, the in situ 
hybridization buffers require high levels of formamide (50%).  Second, the 50-55 
nucleotide probes may not penetrate tissues as well as cultured cells.  We thought that 
the ‘Stellaris probe’ method (BioSearch Technologies) might help to address these issues.  
These 20 nucleotide length DNA oligonucleotides are cocktails of 22-48 probes that are 
directly labeled with a fluorophore.  The shorter length should give greater tissue 
penetration and they do allow for lower formamide concentrations (10-20%) that should 
conserve epitopes for subsequent IF.  Although these probes worked quite well in 
cultured neurons, I consistently failed to detect any signal above the background in 
axons for the tissue sections.  I was able to get appreciable signal from neuronal cell 
bodies in tissue sections, and further found a means to post-fix the hybridized sections 
for greater signal longevity that is now being used in our lab for cultured neurons.  The 
lower formamide concentrations for the Stellaris probes also gave much better signals 
for axonal proteins by IF.  
The unsuccessful trial of shorter probes did emphasize that the 50% formamide 
in our standard hybridization buffer decreases IF signals for many of our target proteins.  
Since the DIG probes did work in my hands for ‘tissue FISH’ (Yoo et al., 2013),  I focused 
on increasing probe penetration for those longer oligonucleotides and increasing our IF 
signals for identifying axons.  Increasing detergent for permeabilization (from 0.1% to 
0.3% triton-X100) gave better signals for these FISH probes.  I also moved to a 
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proprietary ‘blocking buffer’ (Roche) for both primary and secondary antibody 
mixtures.  Although this increased the signal-to-noise ratio (i.e., antisense probe vs. 
scrambled probe signals), I thought we could still improve the detection.  Thus, I further 
amplified the hybridization signals by adding a fluorescently conjugated anti-mouse or 
anti-sheep antibody to bind to the fluorescent anti-DIG antibody that recognizes the 
hybridized probe.  In all cases, scrambled probes, no primary antibody, and no probe 
samples were generated to ensure specificity of my detection.  Finally, for the PNG 
samples, I established cocktails of antibodies to detect axonal proteins, combining 
optimized neurofilament triplet antibodies with SCG10 antibodies to boost my ability to 
visualize axons; this proved quite advantageous in the subtraction and quantification 
methods outlined below.   
Most of the work from our and other labs have focused on small segments of 
axons for analyses of localized mRNAs.  With the optimized FISH/IF approach above, I 
realized that we could use tile scanning to cover long segments of axons and gain more 
insight into the spatial distribution of axonal mRNAs.  Thus, I developed a confocal 
imaging sequence with tile scanning using high magnification objectives for maximum 
resolution of signals.  This led me to the novel finding that the mRNAs were not evenly 
distributed in each axon or between axons (see Figure 5, Chapter 2).  Non-neuronal 
signals also complicated our axonal quantifications, so I developed a post-processing 
sequence using the RG2B plug-in for Image J.  This allowed me to subtract away the non-
neuronal FISH signals by projecting the FISH signal that overlapped with axonal 
markers in individual optical planes to a separate ‘axon only’ channel.  This also 
provided a level of signal normalization as the FISH signal was averaged against the 
signal intensities of the axonal markers.  Through this approach, I was able to visualize 
axonal mRNAs in the PNGs and sciatic nerve and directly compare signals against one 
another for individual mRNAs.  
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 With the approach above, I was able to clearly show that when provided a 
permissive growth environment of the PNG, ascending spinal axons contain mRNAs 
and translational machinery.  The latter includes translation factors, ribosomal proteins, 
and rRNA that would be needed to locally generate proteins in the axons.  Previous 
work from our lab indicated that mRNA localization changes in response to 
environmental stimuli, with local application of neurotrophins to axon termini 
increasing levels of growth-associated protein mRNAs (Willis et al., 2007).  The growth 
inhibiting stimuli MAG and Sema3a decreased transport of the several growth-
associated protein mRNAs, but increased transport of mRNAs encoding ER-stress 
associated chaperone proteins (Willis et al., 2007).  Work from the Jaffrey lab has also 
shown that CSPGs can trigger translation of RhoA mRNA in distal axons (Walker et al., 
2012, Wu et al., 2005).  These observations suggest that extracellular stimuli that modify 
axon growth converge on the mRNA transport and translational machinery in axons.  
My observations for RNA localization and protein synthesis machinery in ascending 
spinal cord axons regenerating into a PNG may reflect the positive environment of the 
PNG converging on these axonal mechanisms.   
 
Role of locally synthesized growth associated proteins in regenerative axon growth – 
Many of the mRNAs that we chose to study in Chapter 2 encode for proteins with 
known roles in axon growth and regeneration.  As mentioned before, GAP-43 and β-
actin proteins are growth promoting and increased GAP-43 protein levels have been 
shown in axons in models of PNS and CNS injury (Skene and Willard, 1981).  Locally 
synthesized GAP-43 protein increases axon length and locally synthesized β-actin 
protein increases axon branching (Donnelly et al., 2013, Yoo et al., 2013, Bird et al., 2013).  
Neuritin (also called CPG15) has been linked to neurite growth and synaptogenesis 
(Merianda et al., 2013, and references within, Akten et al., 2011, Javaherian and Cline, 
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2005).  Transport of this mRNA into sensory axons is increased after axotomy and 
overexpression of an axonally-targeted neuritin mRNA increases growth significantly 
more than overexpression of a cell body-restricted neuritin mRNA (Merianda et al., 
2013).  Importin-β1 mRNA is constitutively transported into PNS axons, but it 
translation is locally increased by axotomy (Hanz et al., 2003).  Locally translated 
Importin-β1 protein forms a retrograde signaling complex that is needed for injury-
induced gene transcription in sensory neurons (Perry et al., 2012).  I showed that each of 
these growth-associated mRNAs localize into the ascending spinal cord axons 
regenerating into the PNGs.  
Reg3a and Hamp mRNAs were also transported into the PNG axons, but 
functions of the proteins encoded by Reg3a and Hamp mRNAs are not known to be 
involved in regeneration.  Unpublished axonal RNA profiling indicated that both 
transcripts show increased axonal levels in injury-conditioned compared to naïve 
sensory neurons in culture (data not shown).  Levels of both mRNAs were reported to 
increase in DRG cell bodies after sciatic nerve and spinal cord injury (Michaelevski et al., 
2010, Blesch et al., 2012).  For PNS sciatic nerve injury, the increased transcription of 
Reg3a and Hamp genes required localized translation of the transcription factor Stat3α 
in axons (Ben-Yaakov et al., 2012).  So at least at a circumstantial level, Reg3a and Hamp 
mRNAs could also encode growth-associated proteins.   
  Reg3a, also known as pancreatitis-associated protein-II (PAPII) in rats, is a 17 
kDa secretory protein and a member of the C-type lectin family.  These proteins have 
low expression during normal conditions but are strongly expressed during acute 
pancreatitis (Graf et al., 2002).   Antibody neutralization of all rat Reg3 isoforms (PAPI, 
PAPII and PAPIII) has been shown to worsen the severity of tissue damage from 
pancreatitis.  However, Reg3a also appears to contribute to other cellular processes.  The 
Zenilman group showed that macrophages that were incubated with recombinant Reg3a 
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protein, formed cell aggregates with increased production of several cytokines 
including IL-6 and TNF-α, (Viterbo et al., 2008).  This effect was speculated to occur 
through an NF-κB signaling pathway, and Reg3a was shown to trigger translocation of 
NF-κB to the nucleus, which results in degradation of IκBα protein (Viterbo et al., 2008).  
Recently, Reg3a was shown to have a role in a sensory neuron model for neuropathic 
pain.  Reg3a protein expression is increased in DRG axons after sciatic nerve injury or 
induction of inflammation (He et al., 2010).  Increased production of IL-6 in injured 
nerves has been linked to regeneration, but this appears to be an early event after sciatic 
nerve injury so it is not clear how the axonally synthesized Reg3a protein functions.  
Hamp mRNA encodes the Hepcidin protein, which functions in iron metabolism 
(Zechel et al., 2006).  Recently, Qian et al. (2014) showed that LPS (lipopolysaccharide) 
induced inflammation mediates IL-6 release from macrophages and stimulates STAT3 
phosphorylation in neurons.  Translocation of phosphorylated STAT3 to the nucleus 
mediates Hamp gene expression, which in turn leads to increased Hepcidin expression 
and secretion, and downregulates Ferrorportin 1 expression (Qian et al., 2014).  IL-6 
expression is increased following axotomy in the peripheral nerve, and in retinal 
ganglion neurons after optic nerve injury (Cao et al., 2006, Leibinger et al., 2013).  It is 
possible that increased expression of Hepcidin could prevent iron transport, preventing 
toxic iron uptake by neurons and glia.  It will be of interest to see if axonally synthesized 
Hepcidin protein has any neuroprotective role following axotomy.   
 It is well established that when the inhibitory environment of the injured spinal 
cord is removed, CNS axons can regenerate (Chew et al., 2012).  However, it was not 
clear if the mechanisms of growth in these regenerating CNS axons overlap with those 
of the spontaneously regenerating PNS.  My study shows for the first time this 
regenerating CNS axons likely have the capacity to synthesize proteins autonomously 
from their cell bodies.  We do not know if the locally synthesized proteins contribute to 
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growth of these CNS axons as our lab has shown for PNS regeneration.  If this is the 
case, then RNA transport and localized protein synthesis could indeed present a new 
therapeutic target to increase axon regeneration and successful neural repair after spinal 
cord or brain injury.  
 
Future studies for intra-axonal protein synthesis in regenerating CNS axons – The 
studies outlined in Chapter 2 and discussed above support the notion that CNS axons 
can locally synthesize proteins when they are provided a permissive growth 
environment.  Future studies will be needed to determine if CNS axons regenerating 
within the CNS white matter, rather than a PNG as used here, will behave similarly.  
This could be addressed with the PNG model by assessing mRNA and translational 
machinery content as axons leave the PNG and enter the spinal cord.  The Houle lab has 
improved fluorescent tracing methods so they are now able to trace axons as they enter 
and exit the graft (Sachdeva et al., in review).  Performing similar studies as done in 
Chapter 2 on these axons will be of great interest.  
 Another way to study regenerating CNS axons in their normal environment is 
recent advances from the He group in deleting phosphatase and tensin homolog (PTEN) 
gene (Park et al., 2008, Liu et al., 2010).  PTEN is a tumor suppressor and a negative 
regulator of the mammalian target of rapamycin (mTOR) pathway.  Under normal 
conditions the optic nerve fails to regenerate, but under conditional knockdown of 
PTEN and induction of inflammatory responses with zymosan, optic nerve axons show 
robust regeneration even though traversing a non-permissive environment with 
inhibitory CNS myelin and CSPGs (for review see (de Lima et al., 2012).  In initial pilot 
studies (collaborating with Drs. Larry Benowitz and Matt Rasband), I have been able to 
detect GAP-43 and Reg3a mRNAs in regenerating optic nerve axons in the PTEN 
knockout animals treated with Zymosan (Figure 2).  This approach will be optimized to 
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compare axonal levels of mRNAs between naive, injured, and regenerating optic 
nerve axons following the approaches established in Chapter 2.  
 The finding that Reg3a and Hamp mRNAs transcription and axonal transport are 
increased after injury begs the question of what role the locally translated proteins have 
in axon regeneration.  There has been no direct evidence that either REG3a or Hepcidin 
proteins are involved in axon growth.  The proteins are widely upregulated by 
inflammation (Lee et al., 2005, Wrighting and Andrews, 2006, Gnana-Prakasam et al., 
2008, Frazier et al., 2011, He et al., 2010), which also occurs at the site of PNS axon injury. 
Future studies will need to test the functions of Reg3a and Hepcidin proteins in axon 
growth.  This will also need to address the generalized functions of these proteins as 
well as assess the localized functions.  Generalized functions can be tested by depletion 
and overexpression.  Incorporation of ‘UTR swapping’ approaches into overexpression 
constructs can be used to distinguish localized and cell body restricted roles by targeting 
the mRNA into axons (Donnelly et al., 2013, Merianda et al., 2015).     
I have generated fusion constructs with the 5’ of CAMKIIα mRNA (which does 
not localize to axons) and the 3’UTR of either Reg3a or Hamp mRNAs to a myristolated 
GFP.  Since we have previously shown that 5’UTRs can also be responsible for 
localization to axons (Merianda et al., 2013), we generated the same constructs swapping 
the 5’UTR of CAMKIIa with Reg3a or Hamp mRNAs, and used CAMKIIa 3’UTR 
instead.  This will allow me to determine the axonal targeting elements of these two 
mRNAs; most targeting elements have been within 3’UTRs of axonal mRNAs analyzed 
in our laboratory.  Reg3a mRNA has two splice variants with different 5’ UTRs, so I 
generated constructs with both variants.  According to the UTR database 
(http://utrdb.ba.itb.cnr.it/.) the longer 5’UTR of Reg3a mRNA also has an IRES 
sequence, but this has not been experimentally tested.  These constructs will enable me 
to do so.  
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Pilot siRNA studies have already been used to determine if knockdown of 
Reg3a or Hamp mRNA leads to decreased axon growth.  We have utilized siRNA 
nanoparticles that are fluorescently labeled with Cy3 fluorophore and have ~95% 
transfection efficiency in DRG neurons.  Interestingly, depletion of Reg3a increases axon 
length, while depletion of Hamp decreases axon length (Figure 3).  If this observation 
with Reg3a holds up, this will be the first axonally generated protein that attenuates 
growth to the best of our knowledge.  This brings an exciting opportunity to determine 
axon growth can be further augmented by combining Reg3a depletion with other 
measures shown to increase axon growth (e.g., axonally targeted GAP-43 mRNA 
(Donnelly et al., 2013, Yoo et al., 2013, Bird et al., 2013)).  
 
 
Mechanism of action of an intrinsic growth program that overcome inhibitory 
extrinsic factors 
 
Post-translational modifications of tubulin – Developing axons navigate through their 
environment stimulated by positive and negative cues that guide them to their proper 
synaptic targets.  When an axon encounters a negative stimulus it will either retract or 
turn away, which requires cytoskeletal rearrangements in the growth cone (described in 
Chapter 1).  In response to positive guidance cues, microtubules asymmetrically invade 
the growth cone, directed towards the stimulus, and the growth cone trajectory moves 
towards the positive stimulus.  Negative guidance cues do the opposite inhibiting 
microtubule protrusion into the growth cone and F-actin polymerization at the stimulus 
(Gallo and Letourneau, 2004).  Thus the dynamics of the cytoskeleton within the growth 
cone dictate both directionality and morphology of the growth cone.  
 Tubulin proteins can undergo several post-translational modifications that affect 
microtubule dynamics and interaction(s) with other cellular components (Song and 
Brady, 2015).   These modifications can occur on soluble tubulin dimers or microtubules.  
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Most α-tubulins contain a C- terminal tyrosine residue (the exception is Human 
TUBA4A and TUBA8, which have terminal glutamate or phenylalanine residues, 
respectively) (Song and Brady, 2015).  Tubulin tyrosination is thought to correlate with 
dynamic properties of microtubules (Janke and Bulinski, 2011).  Cytosolic 
carboxypeptidase (CCP) removes this terminal tyrosine residue, while tubulin tyrosine 
ligase (TTL) rapidly tyrosinates microtubules (Lafanechere and Job, 2011, Janke and 
Bulinski, 2011).  Mutations in α-tubulin that disrupt the TTL-tubulin interaction have 
been linked to neurodevelopmental disorders (Poirier et al., 2013, Kumar et al., 2010).  
Very recently, the Cavalli lab showed that axon injury in the PNS increases axonal levels 
of tyrosinated α-tubulin in a TTL-dependent manner (Song et al., 2015).  Knockdown of 
TTL delayed phosphorylation of c-Jun, a pro-regenerative transcription factor, thus 
reducing axon regeneration (Song et al., 2015).  It has also been shown that tubulin 
tyrosination is involved in retrograde signaling after injury through the recruitment of 
plus end tracking proteins (+TIPs) (Lomakin et al., 2009, Moughamian and Holzbaur, 
2012).  +TIPs have recently been suggested to facilitate the initiation of retrograde axonal 
transport (Lloyd et al., 2012, Lomakin et al., 2009, Moughamian and Holzbaur, 2012). 
 In contrast to dynamic tyrosinated microtubules, acetylation of α-tubulin had 
been associated with more stable microtubules. The data supporting this observation is 
largely circumstantial based on localization of acetylated microtubules rather than actual 
function (Janke and Bulinski, 2011).  Nonetheless, acetylation of microtubules does have 
functional outcomes beyond microtubule dynamics.  Acetylation occurs at the α-tubulin 
lysine 40 that resides within the lumen of microtubules. Several enzymes acetylate α-
tubulin, including the alpha tubulin acetyltransferase (αTAT/MEC17) (Kalebic et al., 
2013).  HSP90 interaction with microtubules is enhanced by presence of acetylated α-
tubulin, and recruitment of HSP90 to microtubules activates Akt and p53, which 
promotes survival in HeLa cells (Giustiniani et al., 2009).  It has also been shown that 
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molecular motors, Kinesin-1 and Dynein are recruited to acetylated microtubules 
following inhibition of the tubulin deacetylase HDAC6 (Reed et al., 2006, Kawaguchi et 
al., 2003, Chen et al., 2010, Dompierre et al., 2007).  A tight regulation between tubulin 
acetylation and deacetylation has been shown to be important for successful axon 
regeneration in the PNS and CNS (Cho and Cavalli, 2012, Erturk et al., 2007, Hellal et al., 
2011, Sengottuvel et al., 2011).  My data indicate that tubulin acetylation through 
HDAC6 inhibition is supportive of axon growth possibly through growth cone 
stabilization.  While others have shown that HDAC6 inhibition increases acetylated α-
tubulin, I have shown that this is restricted to the distal axon and other cytoskeletal 
components are also affected (Chapter 3, Figure 2).  The change in growth cone 
dynamics seems to promote recruitment of mitochondria to the growth cone, and these 
mitochondria likely have increased function.   
 
Regulation of microtubule dynamics by HDAC6 – HDAC6 plays a major role in 
regulating microtubule dynamics in neurites (Hubbert et al., 2002, Ageta-Ishihara et al., 
2013).  HDAC6 activity seems to regulate the acetylation status of lysine 40 in α-tubulin 
(Hubbert et al., 2002).  A recent report indicates that septin proteins can serve as a 
physical scaffold between HDAC6 and the microtubule allowing for efficient 
deacetylation (Ageta-Ishihara et al., 2013).  Knockdown of Septin 7 in cerebrocortical 
neurons results in excessive stabilization of microtubules and this impairs axon growth 
(Ageta-Ishihara et al., 2013).  Other studies have shown a similar function for HDAC6 in 
dendrites where knockdown of HDAC6 in cerebellar and hippocampal neurons 
decreased dendrite length and branching through its interaction with CDC42 and 
anaphase-promoting complex (APC) (Kim et al., 2009).   
 The work presented in Chapter 3 shows that one-hour chemical inhibition of 
HDAC6 leads to an increase in acetylated α-tubulin levels that is restricted to the distal 
 153!
axon and growth cone.  This is not too surprising, as my studies indicate that 
HDAC6 protein concentrates in the distal axon shaft and growth cone.  In my hands, 
HDAC6 inhibition did not appreciably affect axon growth, although a recent paper from 
Lin et al. (2015) suggested that more chronic HDAC6 inhibition attenuates axon growth 
while inhibition of histone acetyl transferases (HAT) promotes axon growth.  The 
extracellular environment following spinal cord injury is inhibitory to axon growth 
(discussed above).  HDAC6 inhibition has been shown to support growth on the CNS 
inhibitory substrates MAG and CSPG (Rivieccio et al., 2009).  Based on my findings, 
targeted inhibition of HDAC6 in distal axons could prevent axonal retraction and end 
bulb formation after CNS injury through alterations in growth cone cytoskeletal 
dynamics and/or increased mitochondrial transport into distal axons.  The lack of any 
effect of HDAC6 inhibition on basal axonal outgrowth on permissive substrates may 
bring the advantage of preventing overgrowth of injured axons in the absence of 
inhibitory stimuli (i.e., in permissive growth environments like the PNS).  This idea is 
supported by previous work from the Bradke group that showed Taxol treatment 
enhances growth from CNS axons in vivo after injury, but does not increase axon length 
on permissive substrates in vitro (Erturk et al., 2007).  Although it should be noted Lin et 
al. (2015) recently reported a decrease in axonal growth with long durations of HDAC6 
inhibition, so some caution is warranted.  However, we have not been able to detect 
altered axonal outgrowth with longer term HDAC6 inhibition with the doses of 
Tubastatin A used here (data not shown).   
 
Axon transport and mitochondrial function – The stabilization of the growth cone 
following treatment with Tubastatin A might be the mechanism for its neuroprotective 
effect.  As discussed above, molecular motors have been shown to prefer specific 
posttranslational modifications of tubulin, and proper axonal transport is necessary for 
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neural repair (Mar et al., 2014).  Anterograde transport of mitochondria in axons is 
dependent on Kinesin-1 (Hollenbeck and Saxton, 2005).  My work indicates that 
mitochondria accumulate in growth cones when HDAC6 is inhibited.  Kinetic analyses 
indicated that this accumulation likely results from a net shift favoring anterograde 
movement of axonal mitochondria in sensory neurons.  Consistent with my 
observations, other groups have reported increased transport of mitochondria in axons 
(Chen et al., 2010, Kim et al., 2012, Dompierre et al., 2007).  These previous studies used 
longer-term treatments with Tubastatin A and/or higher concentrations of the inhibitor.  
Also, alterations in both anterograde and retrograde movement were reported for these 
analyses in hippocampal neurons (Kim et al., 2012), while my data point indicate that 
anterograde movement was favored and manifests with increased growth cone 
mitochondrial content.  Importantly, my studies allowed me to define the effect of 
HDAC6 inhibition in mitochondrial transport of the same neuron before and after 
inhibition of HDAC6.      
 Previous studies have pointed to a role for HDAC6 in modulating mitochondrial 
function (Kamemura et al., 2012, Lee et al., 2014, Bai et al., 2015).  The Hollenbeck group 
has further shown that mitochondria are actively transported to sites of ATP 
consumption, with transport to non-motile growth cones being restricted (Morris and 
Hollenbeck, 1993, Chada and Hollenbeck, 2003).  Mitochondrial movement is also 
regulated by cytosolic Ca2+ levels, with elevated [Ca2+]intracellular attenuating both anterograde 
and retrograde movement of mitochondria in both neurons and neuronal-like cell lines 
(Rintoul et al., 2003, Yi et al., 2004, Szabadkai et al., 2006).  This is of interest because 
activation of the NgR-p75NTR by MAG leads to an increase in cytoplasmic Ca2+  (Wong et al., 
2002).  It is possible that with increased mitochondria trafficking to the growth cones 
when HDAC6 is inhibited may provide the growth cone with some protection from 
stimuli like MAG that can increase [Ca2+]intracellular locally in growth cones.  Mitochondria can 
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provide a means to buffer Ca2+, and increased ATP production from more 
mitochondria in the growth cones may provide energy needed to maintain structure and 
growth in the presence of growth inhibitory stimuli.     
 Activation of KillerRed that was fused to mitochondria in DRG axonal growth 
cones caused rapid growth cone retraction.  However, the inhibition of HDAC6 
protected axons from this retraction.  In addition, mitochondria rapidly moved into the 
growth cone from unbleached regions, something that was not seen in any of the control 
cultures.  KillerRed is known to induce reactive oxygen species (ROS), and it is possible 
that HDAC6 inhibition reduces the release of ROS from mitochondria upon KillerRed 
activation, however this needs to be tested.  It is also possible that the increase transport 
of mitochondria due to increased acetylated α-tubulin in the axon was sufficient to 
replace the damaged mitochondria thus protecting the growth cone from retraction.   
 
Future studies to dissect mechanisms of HDAC6 growth promoting effects – Although 
my observations on the morphological changes to axons and functional effects of 
HDAC6 inhibition point to mechanisms that underlie its actions, this work is far from 
complete and additional studies are needed.  My work to date has been limited to 
sensory neurons grown on the permissive laminin substrate.  It will be imperative to 
determine how the distal axon and growth cones of HDAC6-inhibited neurons respond 
when exposed to non-permissive substrates like MAG or CSPGs.  The effects that we 
have seen could be protective due to cytoskeletal dynamics or metabolic changes or 
both.  To this end, the analyses of post-translational modifications and live-cell imaging 
studies will need to be compared between permissive and non-permissive substrates.  
Additionally, the question of whether altered transport is seen with other cargos in 
axons after HDAC6 inhibition.  Pilot studies show altered movement of lysosomes and 
Rab7-labeled endosome populations (data not shown), but this work will need to be 
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extended to non-permissive substrates and incorporate physiologically relevant 
ligands (e.g., neurotrophins, APP, and/or tetatanus toxin).   
The CALI experiments suggest that the increased mitochondrial transport and 
growth cone mitochondrial numbers with HDAC6 inhibition may have functional 
implications.  However, my data do not shed any light on what that function may be.  
Future studies will need to dissect the known functions of mitochondria.  Specifically, 
there is a possibility that mitochondrial respiration and resting membrane potential are 
different with HDAC6 inhibition, so this will need to be tested.  Mitochondrial 
respiration can be blocked using Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) or 
Rotenone.  If the effects are not dependent on respiration, the Ca2+ buffering will need to 
be considered and Ca2+ uptake by mitochondria can be blocked at the mitochondrial 
transition pore using Rub360.  It should be noted that Ca2+ influx is a mediator of 
Wallerian degeneration in distal axons after axotomy (Villegas et al., 2014), so similar 
mechanisms could be used during growth cone retraction.  We also have to consider off 
target effects of the pharmacological inhibitor used here in altering mitochondrial 
metabolism, so the above experiments should also be considered in the absence of 
HDAC6 and/or with chemically distinct inhibitors.  Both HDAC6 knockout mice and 
other HDAC6 inhibitors have recently become available to our group.   
 Although I have shown that acetylation of α-tubulin, HSP90 and cortactin 
increases in distal axons with inhibition of HDAC6, there are likely many additional 
substrates for HDAC6 in axons.  Some of these proteins could contribute to or even 
account for the ability of HDAC6 inhibited neurons to grow axons across non-
permissive substrates.  Such HDAC6 substrates could prove to be ‘druggable’, providing 
a more targeted approach than HDAC6 to support regeneration.  My initial studies to 
identify the ‘acetylome’ of axons suffered from low affinity/specificity of commercially 
available anti-acetyl lysine antibody preparations.   Our collaborator for proteomics 
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work has subsequently developed a pipeline for isolation of acetylated proteins from 
low input samples that we hope will provide the sensitivity needed for this work.  In the 
mean time potential substrates for HDAC6 as well as its interacting proteins or partners 
can provide useful information.  Our lab has now generated proximity biotinylation 
reagents using HDAC6 fused to a modified bacterial biotin ligase (BirA; (Roux et al., 
2012).  This will be particularly useful to compare the axonal intractomes of HDAC6 and 
HDAC5 that appear to have opposing actions in axons, a collaboration between the 
Langley, Cavalli, Burlingame, and Twiss labs.  Ultimately, we predict that comparing 
the wildtype to inactive mutants for each protein may provide insight into interacting 
proteins vs. substrates.  Preliminary results from F11 cells indicate the constructs are 
working well and lentivirus preparations will enable advancing to primary neuronal 
preparations and analyses of the axonal compartment.     
Conclusion 
 Under normal physiological conditions the PNS and CNS differ in their 
regeneration capacities.  Over, the last decade some of the mechanisms that support PNS 
axon regeneration have been elucidated.  The failure of regeneration in the CNS has 
been described to be from a lower growth capacity (intrinsic factors) and an inhibitory 
extracellular environment (extrinsic factors).  The sum of my thesis work reflects on each 
of these mechanisms.  My work on spinal cord axons regenerating into peripheral nerve 
grafts in Chapter 2 shows for the first time that spinal cord axons contain mRNAs and 
translational machinery when they can regenerate.  I anticipate that proteins generated 
in these axons will contribute to axon growth, as our lab has documented for 
regenerating PNS axons (Donnelly et al., 2011).  It is quite possible that the inhibitory 
environment of the normal and injured spinal cord may prevent mRNAs and protein 
synthesis machinery from localizing into axons.  This would imply that signals 
generated by the extracellular environment converge on the intra-axonal mechanisms 
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that intrinsically support growth.  Furthermore, my work with HDAC6 in Chapter 3 
points to intracellular mechanisms that underlies the axon’s capacity to grow on non-
permissive substrates.  Specifically, alterations in growth cone structure and/or 
organelles may be used to overcome inhibitory extrinsic stimuli.  Although the neural 
repair field often arbitrarily distinguishes intrinsic factors and extrinsic factors as 
underlying regenerative failure after CNS injury, failed growth ultimately lies with 
mechanisms inherent to the distal axon and my thesis work supports this contention.      
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Figure 1:  GRPs/NRPs exposure increases levels of growth-associated mRNAs in DRG 
axons. 
Relative axonal mRNA levels normalized to Amphoterin mRNA are shown for DRG 
neurons cultured under standard conditions (grey columns) or co-cultured with 
GRP/NRP cells (green columns).  Values are displayed as a fold change relative to 
control ± SEM.  Changes in mRNA were analyzed by RT-ddPCR from at least 3 
independent experiments [* p ≤ 0.05 by one-way ANOVA].  
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Figure 2: Reg3a and GAP43 mRNAs localize into regenerating axons of mouse optic 
nerve. 
Representative images of FISH/IF for Reg3a and GAP43 mRNAs in regenerating optic 
nerve axons from mice with retinal ganglion cell PTEN knockout and Zymosan 
treatment after optic nerve crush.  XYZ projection of image sequence with NF, SCG10, 
GAP43 proteins in green, mRNA in red and DAPI in blue (A,D).  mRNA signal (red) is 
shown for GAP-43 and Reg3a (B,E).  XYZ projection of mRNA (white) that overlaps 
with axonal markers as subtracted with RG2B plugin (C,F) [Scale bar = 5 µm].   
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Figure 3:  Depletion of Reg3a increases axon length in DRG neurons 
Representative images of DRG neurons transfected with either negative control siRNA 
(left) or Hamp siRNA (right) (A, top) or Reg3a siRNA (A, bottom).  Neurons were 
stained with RT-97 NF (grey) [Scale bars = 250 µm].  Quantification of total neurite 
lengths represented as a fold change to negative siRNA controls (light grey bars) for 
Hamp siRNA (C, left) and Reg3a siRNA ± SEM (C, right) [N ≥ 18 neurons across 
multiple experiments; ** p ≤ 0.005; NS = not significant by one-way ANOVA with 
Bonferroni post-hoc analysis].  
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